Biochemical and molecular genetics of ornithine decarboxylase in chickens by Johnson, Ruth
The Biochemical and Molecular Genetics of 
Ornithine Decarboxylase in Chickens 
by 
Ruth Johnson 
Thesis submitted to the University of Edinburgh 
for the degree of Doctor of Philosophy 
Department of Genetics 




I declare that this thesis has been composed by myself, 











Chapter 1 	General Introduction 
1.1 	Polyamine Biosynthesis 
1.2 Functions of the Polyamines 
1.2.1 Inhibition 	of 	Polyamine 	Biosynthesis 
1.2.2 Interaction of Polyamines with DNA, RNA, 
and protein synthesis 
1.2.3 Polyamines and membranes 
1.2.4 Polyamines 	and 	Differentiation 
1.3 ODC inhibitors as chemotherapeutic agents 
1.4 Properties and regulation of ODC 
1.4.1 Rapid turnover of ODC 
1.4.2 Regulation of ODC activity 
1.4.3 Inhibition of ODC and the ODC 'Antizyme' 
1.4.4 Properties of ODC protein 
1.5 Molecular Biology of ODC 
1.6 Aims of this study 
Chapter 2 Materials and Methods 
	
2.1 	Experimental animals 
2-.2--Media- 
2.3 	Chemicals and Isotopes 
2.4 Buffers and sequencing solutions 
2.5 	Bacterial strains 
2.6 Bacteriophage strains 
2.7 Methods 
2.7.1 Ornithine decarboxylase assay 


























2.7.3 Preparation of cells 	 34 
2.7.4 DNA manipulation 35 
2.7.5 Preparation of RNA 	 36 
2.7.6 Blotting and hybridization procedures 	37 
2.7.7 Sequencing methods 	 39 
Chapter 3 ODC Activity in Muscle and Embryos 	41 
3.1 Introduction 42 
3.2 Muscle ODC activity 44 
3.3 Effect of a-difluoromethylornithine 44 
3.4 Embryo ODC activity 49 
3.5 Discussion 54 
Chapter 4 Cloning of putative ODC cDF4A and 
investigation 	of 	the 	organisation 	and 
expression of the gene 58 
4.1 Introduction 59 
4.2 Probing of Southern blots with mouse ODC cDNA 62 
4.3 Isolation of chicken ODC cDNA and genomic clones 64 
4.4 Probing of Southern blots with ODC13 66 
4.5 Expression of ODC in muscle 68 
4.6 Discussion 69 
Chapter 5 	Sequencing and analysis of putative 
chicken ODC cDNA 71 
5.1 Introduction 72 
5.2 Subcloning and sequencing of ODC13 74 
5.3 Features of the ODC13 cDNA sequence 76 
5.4 Features of the predicted amino acid sequence 84 
5.5 --Discussion 	 - 	 - 	 - 	
- - 87 
Chapter 6 General discussion and conclusions 	89 
6.1 Why investigate ODC ? 	 90 
6.2 Use of the inhibitor DFMO 93 
6.3 ODC and muscle growth 	 96 
6.4 ODC activity in embryos 98 
6.5 The chicken ODC cDNA 	 -99 
6.6 The organisation of the ODC gene 	 102 
6.7 Expression of ODC 	 103 
6.8 	Further investigation 105 
6.9 Summary and conclusions 	 106 
References 	 109 
ACKNOWLEDGEMENTS 
I would like to thank the following people for their many and 
varied contributions to this thesis: 
Grahame Bulfield, for his supervision, support and 
encouragement, and for persuading me I was capable of 
doing this; 
Andy Tait and D.E.S. Truman, for interesting and extremely 
useful discussions; 
Diana Fawcett, Chris Goddard, and Alex Gray, for invaluble 
assistance, lively debate and considerable amusement; 
The A.F.R.C. for financial support, the computing and 
photography departments of I.A.P.G.R. and the photography 
department of H.G.U. for their patience and help in 
preparation of this thesis; 
Most of all, my parents, without whom I would never have 
got this far; and last, but certainly not least, Ian, for love 
and support, and tolerance above and beyond the call of duty. 
Iv 
ABSTRACT 
The role of ornithine decarboxylase (ODC) was investigated in 
muscle and embryos of different chicken lines selected and 
unselected for increased growth and weight-for-age. Both lines 
showed a peak in muscle ODC activity at 5-6 days post hatch 
which can be up to 4-fold higher in the selected line. Use of a-
difFuoromethylornithine (DFMO) to try to inhibit this activity in 
the selected line produced birds which had significantly lower 
body weight, but not muscle weight or muscle ODC activity, than 
control birds. It seems that treatment may have been started too 
late (4 days post-hatch) to have a significant effect on muscle 
ODC activity, but still affected overall growth rate. 
ODC activity in embryos showed a peak at 4-5 days. This 
was found to be highest in embryos from strains which showed 
fastest growth rates at this particular stage, but this did not 
necessarily reflect the pattern found in post-hatch growth. In all 
strains examined at this stage the ODC activity was found to be 
higher in the head region than in the rest of the embryo. 
A cDNA clone was isolated from a chicken embryo cDNA 
library using a mouse ODC probe. The DNA sequence of this clone 
was found to be 78% homologous to the human ODC sequence and 
almost 90% homologous at the amino acid level. This amount of 
sequence conservation suggests an extremely important role for 
this enzyme. 
V 
This cDNA hybridized to several bands in chicken genomic 
DNA in a way which suggests that there is only a single ODC gene 
in chickens. It also detected a HaellI polymorphism between 
broiler and layer strains which is at the 3' end of the gene. 
Probing Northern blots with this probe indicated the presence of 
two transcripts, which closely correspond both to the size 
predicted from the cDNA clone and to the size of mRNAs found in 
other species. 
It is suggested that many pathways of investigation are 
opened up by the work presented here. Future investigation might 
involve use of the chicken ODC cDNA to investigate the cause of 
the differences in ODC activity between strains, cloning of the 
chicken ODC gene, and the use of transgenics to study the role of 
ODC in growth and development. Myoblasts and satellite cells in 
culture will also provide a useful system for studying ODC 
activity and expression and its involvement in muscle growth. 
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ABBREVIATIONS 
14C Ornithine L-[1- 14 C]Ornithine 	hydrochloride 
32p dCTP Deoxycytidine 	5'-[a- 32 P]triphosphate, 
triethylammonium 	salt 
35S dATP Deoxyadenosine 	5'-ct[35S]th iotriphosp hate, 
triethylammonium 	salt. 
A Adenine 
ATPase Adenosine triphosphatase 
C Cytosine 
cAMP Cyclic adenosine monophosphate 
cDNA Complementary DNA 
O-D Chinese hamster ovary 
CNS Central nervous system 
DEP Diethylpyrocarbonate 
DFTvO a-Difluromethylornithine 
dH20 Distilled 	water 
LJvISO Dimethylsuiphoxide 
DNA Deoxyribonucleic 	acid 
DNase Deoxyribonuclease 
DIT Dithiothreitol 
EC Embryonal carcinoma 
MF Epidermal 	growth 	factor 
EDTA Disodium 	ethyleriediaminetetraacetate 
FGF Fibroblast 	growth 	factor 
G Guanine 
VII 
0-1 Growth hormone 
HTC Hepatoma tissue culture 
IGF Insulin-like 	growth 	factor 
IP Inositol 	monophosphate 
kb Kilobase pairs 
kd Kilodalton 
K-MES Potassium 	2-[Nmorpholino]- 
ethanesu Iphon ate 
Klerow DNA polymerase 1, Klenow fragment 
MOPS 3-[N-Morpholino]propanesulphonic 	acid 
Mr Molecular weight 
mRNA Messenger RNA 
Nerve growth factor 
CID Optical 	density 
(IC Ornithine decarboxylase 
PEG Polyethylene 	glycol 
P1 Phosphotidylinositol 
PIPES 1 ,4-Piperazinediethanesulphonic 	acid 
PMA Phorbol 	myristic 	acetate 
RNA Ribonucleic acid 
RNase Ribonuclease 
SAMDC S-Adenosylmethionine 	decarboxylase 
s.e.m. Standard error of the mean 
SIDS; Sodium dodecyl sulphate 
T Thymine 
t1/2 Half-life 
TCA Trichioroacetic 	acid 
El 
VI,' 
TGF-13 	 Transforming growth factor 
TPA 	 Tetradecanoyl phorbol acetate 
Tris 	 Tris[hydroxymethyl]aminomethane 




Much research has been directed towards pinpointing genes 
controlling commercially important traits, such as growth, in 
animals used for food production. This is an extremely difficult 
task because of the number of genes involved in the control of 
these characteristics (Bulfield, 1980). Many years of selection 
have produced animals which differ dramatically in growth rate, 
body mass, and muscle weight, compared to unselected lines. 
Obviously, to be able to control or manipulate these 
characteristics would be of great commercial value, but it is 
first necessary to identify the so called 'trait genes'. So far 
little progress has been made in identifying these genes. One 
approach to this question is to examine whether specific genes, 
whose products have been implicated in growth regulation, are 
those on which selection for growth acts. One such gene product 
is ornithine decarboxylase (ODC) which has been implicated 
because of its well established connection with increased 
growth rate and rapid response to mitogens (for reviews see 
Tabor & labor, 1976; 1984). In poultry, ODC activity was found to 
be elevated in muscle, but not other tissues, of broiler lines 
selected for growth and muscle mass (Bulfield et a!, 1988). 
These observations along with others described in this chapter, 
make ornithine decarboxylase worthy of investigation as a 
commercially important gene in selection for growth and a 
potential target for manipulation. 
2. 
1.1 POLYAMINE BIOSYNTHESIS. 
Ornithine decarboxylase is the first enzyme in polyamine 
biosynthesis and regulation of its activity may determine the 
flux through the pathway (see Figure 1.1). It catalyses the 
formation of putrescine from ornithine and in animal tissues this 
is the only pathway for synthesis of putrescine. Formation of the 
higher polyamines, spermidine and spermine is catalysed by 
spermidine synthase and spermine synthase respectively. In 
these reactions putrescine and spermidine receive an 
aminopropyl group from decarboxylated S-adenosylmethionine 
which is formed by the decarboxylation of S-adenosylmethionine 
by S-adenosylmethionine decarboxylase (SAMDC). Changes in 
SAMDC activity often occur in response to the same stimuli 
which cause changes in ODC activity suggesting that it is also 
implicated in control of the rate of polyamine biosynthesis. 
All eukaryotic cells contain polyamines and their presence 
is necessary for normal cell growth and development (Canellakis 
et al ,1979; Pegg, 1986; Tabor & Tabor, 1984). The exact function 
of the polyamines is not well understood, although their 
involvement in many important cell functions is well documented 
(see below). 
Levels of polyamine biosynthesis vary throughout the cell 
cycle. Cress and Gerner (1980) have shown that when Chinese 
hamster ovary (CHO) cells in culture are stimulated to divide, 
increased polyamine biosynthesis, indicated by a rapid rise in 
ODC activity, occurs early in Gi phase. A second peak in ODC 
activity occurs at late Gi/early S phase, immediately before DNA 
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and RNA replication. They also found that in continuously dividing 
CHO cells, the early Gi peak in ODC activity is not observed and 
it appears to occur only when cells are stimulated to divide from 
a quiescent state. Addition of hydroxyurea blocked the induction 
of ODC in the continuously dividing cells but had no effect on ODC 
activity in stimulated cells. This implies that different 
regulatory mechanisms are acting in the two different systems. 
Arrest of the cell cycle in BALB/c-3T3 fibroblasts by a-
difluoromethylornithine (a specific irreversible inhibitor of ODC) 
is at Gi-phase and can .be reversed by the addition of putrescine, 
indicating that the cell cycle arrest is a result of polyamine 
depletion (Charollais & Mester, 1988). 
In human cells a similar pattern of cell-cycle ODC activity 
is seen, but it differs slightly in different cell systems. In 
human T-lymphocytes stimulated to divide, a peak of ODC mRNA 
levels occurs in mid-G1 phase which declines before the cells 
enter S phase. However in serum-stimulated fibroblasts an 
elevation of ODC mRNA persists through Gi to S phase with only 
a slight elevation on entering S-phase (Kaczmarek eta!, 1987). 
It has been suggested that the first increase in ODC 
activity seen in early Gi in CHO cells, is not related to cell 
proliferation as it may be induced by stimuli which do not cause 
this effect (Heby, 1981), but it is possible that an increase in 
ODC activity is one of the changes necessary to allow a cell to 
enter Gi phase of of the cell cycle. 
S 
1.2 FUNCTIONS OF THE POLYAMINES. 
1.2.1 INHIBITION OF POLYAMINE BIOSYNTHESIS. 
Much of the investigation of the possible functions of the 
polyamines has involved studying the effects of inhibiting 
polyamine biosynthesis. There are many polyamine synthesis 
inhibitors which work effectively in living cells and most of 
these are reversible and competitive substrate analogues. One of 
the most effective polyamine synthesis inhibitors is a-
difluoromethylornithine (DFMO) which acts by inhibiting ODC 
activity. DFMO is a specific, irreversible inhibitor of ODC which 
has no known effect on any other enzyme (Metcalf et a!, 1978). 
In eukaryotes, inhibition of ODC causes a significant drop 
in putrescine and spermidine levels, but has little effect on 
levels of spermine. This could be because of the efficiency of 
spermidine and spermine synthase in converting any remaining 
putrescine and spermidine to spermine, and also of the 
comparatively long biological half-life of spermine (>11 days). 
Depletion of polyamines when ODC activity is inhibited occurs 
both in prokaryotic and eukaryotic cells. However, in many 
prokaryotes and higher plants the requirement for ODC activity is 
not absolute as polyamines can also be synthesised via L-
arginine and agmatine. 
The effect of inhibiting polyamine biosynthesis with DFMO 
has been studied in many systems both in vitro and in vivo. In 
human lymphocytes in culture it was found that DFMO abolished 
the normal increases in polyamines caused by stimulation with 
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phytohaemagglutin, and this was accompanied by a marked 
suppression of DNA synthesis which could be reversed by 
addition of exogenous polyamines (Holtta at a!, 1979). In L6 
myoblasts, addition of as little as 0.1mM DFMO caused a decrease 
of putrescine and spermidine and inhibited proliferation of the 
cells in culture (Stoscheck at a!, 1982). Again the effects were 
relieved by addition of putrescine or spermidine indicating that 
the antiproliferative effect was due to inhibition of polyamine 
biosynthesis. Polyamine depletion alsb affects chromosome 
structure in cultured cells. DFMO causes chromosome defects in 
CHO cells grown in low serum medium but no abnormalities were 
seen in vivo in either hamsters or humans treated with DFMO 
(Pohjanpelto & Knuutila, 1984; Pohjanpelto et a!, 1988). DFMO 
does affect polyamine synthesis in vivo, however. Partial 
hepatectomy in rats causes a massive induction of CDC activity 
and a rise in DNA synthesis which can be reduced by up to 70% by 
administration of DFMO (Poso & Pegg, 1982). This effect can be 
reversed by putrescine. 
The effect on embryonic growth of inhibiting polyamine 
biosynthesis is also dramatic. Administration of DFMO at the 4th 
day of pregnancy caused arrest of embryonic growth in rats. 
Again this effect was abolished by putrescine (Mendez at at, 
1983). In chickens, depletion of polyamines causes inhibition of 
nucleolar development and reduction of transcription rates in 
early embryos (Lowkvist at a!, 1983; 1986). 
In general, both in vitro and in vivo, the effect of inhibition 
of polyamine biosynthesis is a dramatic reduction in cell 
proliferation and often a parallel reduction in DNA synthesis. The 
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absence of serious toxicity in mammals in vivo (Phojanpelto et 
a!, 1988; Wong et a!, 1987) has important implications for the 
possible chemotherapeutic uses of DFMO (see section 1.3). 
1.2.2 INTERACTIONS OF POLYAMINES WITH DNA, RNA AND 
PROTEIN SYNTHESIS. 
As previously mentioned, polyamine levels are highest in 
late Gi phase of the cell cycle. It is postulated therefore that 
the polyamines are involved in DNA synthesis or preparation for 
it. There is evidence that polyamines effect initiation of DNA 
synthesis (Boynton et a!, 1976), illustrated by the finding that 
polyamine depleted CHO, 313 and Hela cells all show a 
significantly reduced number of active sites of initiation of 
replication (Sunkara et a!, 1979). Other studies point to an effect 
on the rate of replication. In E. coli the DNA chain elongation rate 
is reduced in polyamine deficient cells, and this effect is 
abolished by addition of spermidine to the cells (Geiger & Morris, 
1978; 1980). 
CDC activity and polyamine levels have also been seen to 
rise preceding or concurrent with 	a 	rise in 	RNA 	levels 	(Jain & 
Tyagi, 1987) and it has been suggested that ODC is involved in 
the 	initiation 	of transcription, but this has not been shown to be 
a causal effect. It is true, however, that ODC has a high affinity 
for RNA polymerase 1 (Manen & Russell, 1977; Russell, 1983), 
and it has also been reported that polyamines stimulate the 
synthesis of 131V subunits of RNA polymerase in E. coli (Mitsui et 
r;i 
a!, 1984), and these could be pathways for its involvement in the 
initiation of transcription. 
There is also much evidence that polyamines can cause 
stimulation of protein synthesis. Polyamines are known to 
promote association of ribosomal subunits in wheat (Sperrazza & 
Spremulli, 1983) and it is also suggested that they increase 
fidelity of translation and chain termination but this effect only 
occurs when Mg 2 concentrations are low and the incubation 
temperature is below 37°C, which makes the relevance of these 
findings to the in vivo situation unclear (Abraham & PihI, 1981). 
It has also been demonstrated that readthrough of the 
termination codon of mammalian RNA can be stimulated by 
polyamines as spermine and spermidine, but not putrescine, 
enhance readthrough of the VGA codon when rabbit mRNA is 
translated in a cell free system. This effect seems to be specific 
for the UGA triplet and does not effect the UAA triplet 
(Hryniewicz & Vonder Haar, 1983). Much of this work has been 
undertaken using in vitro systems, however, and many conditions 
may affect the outcome, such as temperature and ionic 
concentrations. For example many of the effects of the 
polyamines can be reproduced by other divalent or polyvalent 
cations such as Mg 2 , making the relevance of these findings in 
vivo uncertain (labor & labor, 1976). 
1.2.3 POLYAMINES AND MEMBRANES. 
The postulated interactions 	of polyamines and membranes 
are 	mainly due 	to the 	polycationic nature 	of the polyamines, 
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enabling them to form complexes and bridges between anionic 
molecules. This has been shown to cause aggregation and 
stabilisation of protoplasts, mitochondria and erythrocytes (for 
review see Schuber, 1989). The same function may be the likely 
explanation for the disappearance of actin filaments and 
microtubules in polyamine auxotrophic CHO cells when not 
supplemented with putrescine (Pohjanpelto et a!, 1981). 
There is also evidence that polyamines are involved in 
regulation of membrane-bound enzymes, such as Na+,K ATPase 
and acetylcholinesterase, and in transport of ions and 
metabolites (Canellakis et a!, 1979). This is consistent with the 
proposed effect of polyamines in opening of Ca 2 channels and 
stimulation of Ca2" uptake by mitochondria (Schuber, 1989). 
1.2.4. POLYAMINES AND DIFFERENTIATION. 
The positive effect of polyamines on cell proliferation 
seems to be consistent throughout the various systems studied. 
The effect on differentiation, however, varies from one system 
or cell type to 'the next. 
It has been shown that mouse embryonal carcinoma (EC) 
cell lines can be induced to differentiate on depletion of 
polyamines by DEMO (Schindler et a!, 1983). Three classes of EC 
cells were later described which differ in their response to 
DFMO; those in which DFMO caused large decreases in ODC 
activity and polyamine levels showed extensive differentiation 
in response to this agent; those in which polyamine levels were 
decreased only slightly showed poor differentiation; and the 
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lines in which DFMO did not reduce polyamines below a threshold 
level were not induced to differentiate (Schindler et a!, 1983). 
This indicates that a drop in intracellular polyamine levels is a 
factor involved in the stimulation of differentiation of these cell 
lines. 
With human promyelitic leukemia cells it was shown that 
although increases in ODC activity and putrescine content 
accompanied the onset of both proliferation and differentiation, 
inhibition of ODC activity with DFMO suppressed proliferation 
but not differentiation (Luk et a!, 1982). 
In some cell systems, on the other hand, polyamine 
depletion inhibits differentiation and there are three types of 
cells in which this has been extensively studied. Differentiation 
of Friend erythroleukemia cells is blocked by specific inhibitors 
of polyamine biosynthesis, eg. u-methylornithine (Gazitt & 
Friend, 1980), and some inducers of differentiation in this 
system, such as dimethyl sulphoxide, require polyamines to 
trigger differentiation (Gazitt, 1981). Mouse 3T3 fibroblasts 
also show a requirement for polyamines to differentiate. DFMO 
inhibits differentiation in these cells in a dose dependent 
manner, an effect which is abolished by addition of exogenous 
putrescine or spermidine (Bethell & Pegg, 1981; Taylor et a!, 
1988). A similar situation is found in L6 myoblasts where it has 
been shown that ODC activity is necessary for proliferation of 
these cells and that in differentiated myotubes ODC activity is 
more than 100 times lower than in undifferentiated myoblasts 
(Stoscheck et a!, 1980; 1982). When stimulated to differentiate 
with insulin, levels of putrescine and spermidine in myoblasts 
increase and if this increase is blocked with DFMO 
differentiation is inhibited (Erwin et a!, 1983). In this 
experimental system DFMO was added as the myoblast cells 
approached confluence and had no effect on the DNA content of 
the cells. This supports the suggestion that the effect of DFMO on 
myoblast differentiation is not secondary to the previously 
demonstrated effect on proliferation. However, in many cases it 
is difficult to dissociate the proliferative effects of ODC 
activity and polyamines from the effect on differentiation, and 
some events in the differentiation process may depend on cell 
proliferation and polyamine biosynthesis. 
1.3 ORNITHINE DECARBOXYLASE INHIBITORS AS 
CHEMOTHERAPEUTIC AGENTS. 
The demonstration that polyamines play an important role 
in the growth and development of micro-organisms as well as 
mammals prompted the idea that polyamine biosynthesis could be 
a target for drug action. In particular, the potential of ODO 
inhibitors as chemotherapeutic agents has been investigated 
(Fozard & Koch-Weser, 1982; Russell, 1980). The most 
successful application has been the use of DFMO against African 
trypanosomes (Bacchi et al, 1980). Mice infected with 
Trypanosoma brucei brucei, which is normally lethal 4-6 days 
after infection, showed a dramatic response to administration of 
1-2% DFMO in the drinking water. Further studies also 
demonstrated the effectiveness of DFMO against other 
trypanosome infections in mice, and the reversal of the 
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therapeutic effect by administration of putrescine indicates that 
inhibition of ODC is the mechanism of action (Sjoerdsma, 1981). 
These results were followed by similar effects in clinical trials 
on patients infected with I b. bruce! (Sjoerdsma & Schechter, 
1984) demonstrating the potential of DFMO as a therapeutic 
agent in treatment of trypanosome infections. DFMO has also 
been found to be effective in the treatment of coccidiosis caused 
by Eimeria tenella in chickens (Hanson et a!, 1982). The main aim 
of further investigation in this area is the development of new 
inhibitors of ODC which are more potent and longer acting 
(McCann et a!, 1983). 
DEMO has also been tested for action against tumour 
growth. In cell culture it inhibits DNA replication and cell 
proliferation (Janne et a!, 1978), and some promising results 
were also obtained in experimental animals, particularly in 
combination with other agents. For example DFMO and interferon 
in combination were shown to have a significant effect in 
reducing B16 melanoma growth in mice (Sunkara et a!, 1983). 
However, in human trials DFMO has failed to show convincingly 
any real antitumour effect, despite the fact that patients are 
tolerant to high doses and serious toxicity rarely occurs. 
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1.4 PROPERTIES AND REGULATION OF ORNITHINE 
DECARBOXYLASE. 
1.4.1 RAPID TURNOVER OF ORNITHINE DECARBOXYLASE 
The most striking feature of ODC is its extremely short 
half-life in mammalian cells. It has the shortest known half-life 
of any enzyme. This rapid turnover of ODC protein has been 
reported in a number of cells and tissues. For example, in rat 
liver the t112 was found to be about 10 minutes (Russell & 
Snyder, 1968), in mouse kidney it is around 15 minutes (Seely & 
Pegg, 1983; lsomaa et a!, 1983) and in HTC cells it has been 
measured to be as little as 5 minutes (Hogan & Murden, 1974). 
However this appears to vary depending on the state of the cell 
and the growth conditions at the time of measurement. 
One of the mechanisms by which an increase in ODC 
activity can occur is by an increase in the t1,2 of the enzyme 
(Morris & Fill ingame,1974). In androgen stimulated mouse kidney 
the half-life increases from 10-15 minutes to 60-90 minutes 
(lsomaa et a!, 1983; Seely et a!, 1982a), or 100-150 minutes 
(Catterall et a!, 1986) after administration of testosterone, and 
in lymphocytes in culture the half-life can be increased three-
fold by amino acid supplementation of the medium (Kay et al, 
1972). An increase in half-life of ODC has also been reported in 
DFMO resistant cells (McConlogue & Coffino, 1983a) and this 
could be one factor involved in the increased ODC activity which 
leads to DFMO resistance. 
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The short half life of ODC and its apparent stabilization 
under growth stimulated conditions could be a mechanism for its 
regulation by many trophic stimuli. 
1.4.2 REGULATION OF ODC ACTIVITY. 
The induction of ODC activity by a multitude of stimuli 
such as growth hormone, EGF, IGF-1, testosterone, oncogenic 
transformation, TPA, and after partial hepatectomy has been 
well documented (see reviews by Canellakis et a!, 1979; 
Maudsley, 1979; McCann, 1980; Tabor & labor, 1984). Most of the 
investigation of the regulation of ODC has been in mouse or rat 
cells and these do not always show the same responses. A four-
fold increase in ODC activity was found after growth hormone 
administration in rat liver (Janne & Raina, 1968). This was 
accompanied by a corresponding increase in putrescine and 
spermidine levels. Rat P012 cells have also been used to study 
induction of ODC activity. ODC in these cells is induced by nerve 
growth factor in a dose-dependarit manner with a parallel 
increase in ODC mRNA. This response is fully blocked by 
actinomycin-D indicating that transcription is necessary for the 
effect (Feinstein et a!, 1985). It is possible that two different 
induction mechanisms are working in P012 cells since cell lines 
defective in cAMP-dependant protein kinases will still show 
induction of ODC activity in response to NGF but not in response 
to stimuli which act via the cAMP pathway, such as 
chloroadenosine (Van Buskirk et a!, 1985). 
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PC12 cells also show an increase in ODC activity in 
response to insulin, as do rat fibroblasts and hepatoma cells 
(Rinehart at a!, 1985; Goodman at a!, 1988). Insulin and phorbol 
ester induction of ODC in rat hepatoma cells is time and dose 
dependant. There is evidence in this system for more than one 
mechanism of induction. Insulin and PMA have an additive effect 
on ODC activity and addition of PMA after maximal induction by 
insulin causes a further rise (Goodman at a!, 1988). Some other 
stimuli found to cause increases in ODC activity in rat tissues 
include; insulin in brain (Roger & Fellows, 1980); human 
gonadotrophin and pregnant mare gonadotrophin in ovary (Sertich 
at a!, 1987; Lee & Dias, 1988); estrogen in uterus (Branham at at, 
1988); and cortisol in kidney (Bullock, 1983). Interestingly, 
cortisol and estrogen do not induce ODC activity in the 
corresponding tissues in mouse. 000 activity in mouse can also 
be induced by many stimulU but the most studied and probably 
the most effective induction is by androgens in the kidney. 
Bullock (1983) reported an increase in mouse kidney 000 activity 
of up to 100 fold in response to a single dose of testosterone and 
induction of 600-1000 fold after several days of treatment 
(Bullock, 1983; Pajunen et a!, 1982), and the induction was found 
to be dependent on the presence of functional androgen receptors 
in the kidney. 
The mechanism of induction of ODC activity is still not 
clear. In response to testosterone and other mitogenic stimuli an 
increase in ODC protein is reported rather than post-
translational activation (lsomaa et a!, 1983; Seely & Pegg, 
1983). In mouse kidney, androgen stimulation caused an increase 
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in ODC mRNA 6 hours after a single injection (Kontula et a!, 
1984). NOF induction caused an increase in ODC mRNA which was 
quantitatively the same as the effect on activity and followed 
the same time course (Feinstein et a!, 1985). In mouse 
fibroblasts in culture, treatment with growth factors and tumour 
promoters was also found to increase ODC activity via a rapid 
increase in ODC mRNA levels, and was dependent on protein 
synthesis in the cells (Katz & Kahana, 1987). It seems likely 
however that transcriptional activation is only partly 
responsible for the increase in ODC activity as the rise in mRNA 
levels is usually not enough to account for the total rise in ODC 
enzyme activity. 
It was first suggested that induction of ODC activity might 
be mediated by cAMP, but certainly in some cases, this does not 
appear to be true (McConlogue et a!, 1983), although cAMP may be 
the method of signal transduction in certain cells systems, as 
mentioned earlier (Van Buskirk et a!, 1985). Although increased 
cAMP will often cause a rise in ODC activity, in hamster kidney 
cells the mechanism of induction by serum and insulin appears to 
cAMP independent (Hogan et a!, 1974), and there have been 
reports of increased levels of cAMP causing a decrease in ODC 
activity particularly in proliferating cells (Insel & Fenno, 1978). 
More recently another second messenger system has been 
implicated in the control of ODC activity, namely the 
inositol/diacylglycerol system (Jetten et a!, 1985). There is 
evidence that ODC is bound to phosphtidylinositol (P1) at the 
inner surface of the cytoplasmic membrane and is activated 
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when P1 is converted to inositolmonophosphate by a Pt-specific 
phospholipase-C (see figure. 1.2, Mustelin eta!, 1987). 
Induction of ODC activity therefore seems to be under the 
control of several effectors, possibly interacting with each 
other or acting at different times dependent on the cell system 
and the stimuli involved in the induction. 
1.4.3 INHIBITION OF ODC AND THE ODC 'ANTIZYME. 
Inhibition of ODC activity also appears to involve several 
mechanisms. Feedback inhibition by the polyamines spermine, 
spermidine, and putrescine, has been observed in several tissues 
and cell lines (Davis et a!, 1988; Glass & Gerner, 1987; Russell, 
1988). This has been reported to be due to inhibition of 
translation of ODC mRNA although total protein synthesis is 
unaffected (Kameji & Pegg, 1987). In a chinese hamster ovary 
(CHO) cell line which overproduces ODC, putrescine was found to 
modulate 000 activity without changes in ODC mRNA levels, but 
parallel with changes in ODC protein (Dircks et a!, 1986), 
indicating post-transcriptional regulation or activation of 
proteolytic degradation of the enzyme. Recently more evidence 
for post-translational regulation of ODC activity by polyamines 
has been provided. Constructs containing only the protein-coding 
region of the ODO sequence demonstrated regulation by the 
polyamines when transfected into CHO cells, whereas other 
constructs containing the 5' leader sequence but none of the 
coding region did not (Van Daalen Wetters et a!, 1989). 
A -? __ 	active 
PK - C 
IP 
ODC 
protein 	_- QDCmRNA 
synthesis 
FIGURE 1.2 PROPOSED MODEL FOR INTERACTION 
BETWEEN P1 AND ODC (from Mustelin at a! 1987). 
IT) i tog en 
V 
R = receptor for milogen. G = C-protein, PLC = phosphoipase C. 
P1 = phosphat idyl inosilot. IP = inositol-1-monophosphato, DC = di-
acyiglycorol, PK-C = protein kinaso C. 
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There is also evidence for regulation of ODC activity by the 
presence of an inhibitory protein or antizyme' which binds to 
ODC making it inactive. McCann et at (1979) suggested two 
distinct mechanisms for feedback regulation of ODC activity. 
They found that low concentrations of exogenous putrescine 
caused inhibition of ODC activity without detectable ODC 
antizyme, whereas higher concentrations of putrescine 
completely blocked .ODC activity and an ODC-antizyme complex 
could be detected. ODC antizyme has been reported in mouse 
brain, mouse kidney, rat liver, rat lymphoma cells and rabbit 
kidney cells, as well as in prokaryotes such as E coli (Canellakis 
et a!, 1981; Fong et a!, 1976; Heller et at, 1976; Murakami et at, 
1988; Onoue et a!, 1988; Richards et a!, 1981). The reported M 1 
for the antizyme in all these cases is around 26,000; however 
antibodies to brain antizyme show little cross-reactivity with 
antibodies to antizyme from liver, which indicates tissue 
specificity of antizymes despite their similar molecular size and 
reactivity with ODC (Onoue et at, 1988). 
1.4.4 PROPERTIES OF ODC PROTEIN. 
ODC protein of M 1  55,000 has been reported in mouse 
lymphoma cells, calf liver, HIC cells and yeast. Two forms of the 
enzyme have been found in many tissues, differing in ionic charge 
(lsomaa et a!, 1983; Loeb et a!, 1984; McConlogue & Coffino, 
1983a&b; Mitchell et a!, 1985) or, in one case, with different 
molecular weights (O'Brien et a!, 1987). In some cases three 
ionically distinct forms were reported (Haddox & Russell, 1981; 
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Mitchell & Mitchell, 1982), but all reports seem to agree that 
these are probably modifications of the product of a single gene 
rather than different gene products. It appears from the evidence 
presented in these studies that there is interconversion between 
two or three forms depending on the conditions; the form 
normally present being less stable and the other one, or more, 
being formed under stabilizing conditions or when an increase in 
ODC activity is induced. Most of the evidence also supports the 
idea that native ODC is present in a dimeric form made up of two 
53kd subunits (Haddox & Russell, 1981; Seely eta!, 1982b). 
1.5 MOLECULAR BIOLOGY OF ORNITHINE DECARBOXYLASE. 
Much of the difficulty in investigating the properties of 
ODC is due to its low abundance in most tissues. Even in androgen 
stimulated mouse kidney it amounts to only a very small 
proportion of total cell protein (0.01-0.05%). Studies have been 
facilitated, however, by the production of cell lines which vastly 
overproduce ODC. Mouse lymphoma cells were selected for 
resistance to the ODC inhibitor DEMO. These cells synthesised 
ODC at an increased rate and were up to 100 times more 
resistant to DFMO than wild type cells (McConlogue & Coffino, 
1983a). Further selection for resistance to even higher levels of 
DFMO produced a cell line in which synthesis of ODC exceeded 
that of any other protein and amounted to almost 15% of total 
protein synthesis (McConlogue & Coffino, 1983b). Several 
mechanisms were found to be involved in the increase in ODC in 
these cell lines. The cells isolated from the first round of 
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selection which overproduced ODC to a lesser extent were found 
to have increased levels of ODC mRNA or increased rate of 
translation of ODC, or a combination of these two factors. In the 
cell line which had the highest ODC activity it was found that 
there was amplification of the structural gene for ODC. It is 
likely that the two previously mentioned mechanisms were also 
working in this cell line (McConlogue & Coffino, 1983b). 
This cell line was used to clone two overlapping cDNAs 
corresponding to mouse ODC and this was confirmed by in vitro 
translation and immunoprecipitation of the ODC protein 
(McConlogue eta!, 1984). From these clones the mouse ODC cDNA 
sequence was determined (Gupta & Coffino, 1985). Another group 
also isolated and sequenced a mouse ODC cDNA by an almost 
identical approach (Kahana & Nathans, 1984), and they also 
reported that their overproducing cell line had an amplified ODC 
gene and elevated levels of ODC mRNA. 
The cDNA sequence from these altered cells (Gupta & 
Coffino, 1985; Kahana & Nathans, 1985) has been shown to have 
several nucleotide differences when compared to the sequence of 
ODC cDNA from androgen induced mouse kidney (Berger et a!, 
1984; Hickok et a!, 1986). This may be due to the different 
sources of the mRNA used for these studies and it is possible 
that the ODC gene has undergone changes on selection for 
resistance to DEMO. 
ODC cDNA sequences of rat, human and hamster have also 
been reported (Hickok et a!, 1987; Srinivasan et a!, 1987; Van 
Kranen et a!, 1987) as have the genomic sequences of Candida, 
Neurospora, trypanosome, mouse, rat and, recently human 
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(Brabant et a!, 1988; Coffino & Chen, 1988; Eversole et a!, 1985; 
Fonzi & Sypherd, 1987; Holtta et a!, 1989; Philips et a!, 1987; 
Van Steeg et a!, 1988). The intron/exon arrangement in the 
mouse and rat genes, and most likely in human too, is the same 
with the major differences being in intron size, although all 
three have a large first intron of around 2kb. 
Several potential regulatory elements have been identified 
in the mouse, rat and human genes (Coffino & Chen, 1988; 
Fitzgerald & Flanagan, 1989; Wen et a!, 1989). These include a 
TATA box and GC boxes in the 5' untranslated regions which are 
thought to be involved in fixing the site of transcription 
initiation. All three also have a potential cAMP responsive 
element and an AP-2 binding site in the 5' leader sequence and a 
putative AP-1 binding site in the 1st intron (see figure 1.3). 
These are consistent with the regulation of ODC activity by cAMP 
derivatives and phorbol esters. The rat sequence also contains a 
putative glucocorticoid regulatory element in the 1st intron 
which is less well conserved in the mouse sequence. These may 
be involved in the regulation of ODC activity by glucocorticoids 
and androgens. 
In both rat and mouse the presence of multiple pseudogenes 
has been reported (Kahana & Nathans, 1984; McConlogue et a/, 
1984; Wen et a!, 1989), probably at least nine. In the mouse eight 
ODC loci have been assigned to seven different autosomes (Elliot 
et a!, 1985; Richards-Smith & Elliot, 1984), and an X-linked 
member of the ODC gene family has also been identified 
(Stephenson et a!, 1988). The mouse structural gene was first 
tentatively mapped to the distal portion of chromosome 12 
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FIGURE 1.3 SOME POTENTIAL REGULATORY ELEMENTS IN MAMMALIAN ODC GENES. 
CONSENSUS RAT MOUSE HUMAN LOCATION 
TATA box TATAA TATAA TATAA TATAA 5' leader 
GC box c333y33 1333T233 033133 C331X33 5' leader 
ctGCC CGGCcC CGCCC ccccc & 	intron 	1 
G.R.E. TGTTCT TGTTCT TGTCCC intron 	1 
AP-1 UAGTCAG TTAGTCAG TTAGTCAG CTGACTAA 5' leader 
binding GTAGTCAG &intron 	1 
CAMP R.E. TGACGTAC TGACGACG TGACGACG TGGcGACC 5' leader 
(Colombo at a!, 1988) but there is now more convincing evidence 
that it maps to the proximal region of chromosome 12 (Berger, 
1989). Interestingly, this region appears to be homologous to the 
distal region of human chromosome 2p (Cox at a!, 1988). A human 
ODC gene has been mapped to chromosome 2pter+ p23 (Winqvist 
at a!, 1986) which supports the assignment of the mouse 
structural gene to chromosome 12. 
It is likely that only one gene is expressed in mouse, rat 
and human. However, it has been suggested that the two mRNAs 
detected in the mouse could be the products of different genes 
because of the nucleotide differences found in their sequences 
(Berger at a!, 1984; Hickok at a!, 1986). 
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1.6 AIMS OF THIS STUDY. 
From the information reviewed in this chapter, it is 
obvious that ODC is closely linked to growth and is involved in 
rapid and stimulated growth, although a causal effect has yet to 
be conclusively proved. Considerable progress has already been 
made in the study of the molecular genetics of ODC in mammals 
and microorganisms, but there has, until now, been no attempt to 
investigate the molecular genetics of ODC in poultry. Chickens 
provide an ideal system for the study of factors involved in 
growth because of the existence of broiler lines which are 
selected, and layer lines which are effectively unselected for 
growth. 
My initial aim, therefore, was to investigate further the 
increased ODC activity reported in broiler muscle and to try to 
demonstrate a causal effect between ODC activity and increased 
growth in this system, and also to examine the role of ODC in 
embryonic growth in these lines. At the same time I intended to 
approach the subject from a different angle by isolating a cDNA 
for chicken ODC and using this to study the organisation and 
expression of the ODC gene, to attempt to give a better 
understanding of the control of ODC activity in chickens and its 
involvement in muscle growth. 
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CHAPTER 2 
MATERIALS AND METHODS 
2.7 
2.1 EXPERIMENTAL ANIMALS 
The chicken strains used in the experiments described here 
were; Line -101, a commercial broiler strain, derived from a White 
Cornish heavy strain mixed population selected over 36 
generations for weight-for-age and breast muscle development; 
Line 71, a closed population of White Leghorn type, selected for 
egg-production but not for growth; Line ATF. a Rhode Island Red 
based, layer grandparent strain, selected for egg production; Line 
MC, a broiler male line, selected for growth rate, conformation 
and feed conversion efficiency; Line GI, an inbred white leghorn 
strain. 
Line 101, Line ATF and Line MC, were supplied by Ross 
Breeders, Newbridge, Midlothian. Line 71 is maintained at 
I.A.P.G.R. Line GI was from the AFRO Institute of Animal Health, 
Houghton Laboratory. 
The mouse DNA used in Southern blots was from inbred 
strains 057B1/6J and DBN2J, maintained at I.A.P.G.R. 
2.2 MEDIA 
L-broth 
lOg Difco bacto tryptone; 5g Dilco bacto yeast extract; 5g 
NaCl; per litre, adjusted to pH 7.2. 
L-apar 
As L-broth plus 1 Sq/I Difco agar. 
BBL-agar 
lOg Baltimore Biological Laboratories trypticase; lOg NaCl; 
lOg Difco agar; per litre. 
BBL-top 
As BBL-agar but only 7g agar per litre. 
Minimal apar 
6g Difco Bacto agar; 80mis 5x Spizizen salts; 4m] 20% 
glucose; O.lml 5mg/mi vitamin Bi; made up to 400m] with dH20. 
5x Spizizen salts 
75mM (NH4)2SO4; 0.4M K2HPO4; 0.22M KH2PO 4 ; 17mM Tr-
sodium citrate; 4mM MgSO4. 
2.3 CHEMICALS AND ISOTOPES 
a-Difluoromethyiornithine was the gift of Merrell Dow 
Pharmaceuticals Inc. 32p dCTP, 35S  dATP, and 14C  ornithine, 
were purchased from Amersham International U.K. All other 
chemicals were purchased from FSA Laboratory Supplies or Sigma 
Chemical Company, unless otherwise stated. 
2.4 BUFFERS AND SEQUENCING SOLUTIONS 
1OxTBE 
0.89M Tris base; 0.89M Boric acid; 25mM EDIA per litre. 
50 x TAE 
2M Tris base ; 50mM EDTA ; Glacial acetic acid 51.1mls per 
litre. 
Ligase buffer 




22mM KH2PO4; 50mM Na2HPO4 ; 85mM NaCl; 1mM MgSO4; 
0.1mM CaCl2; 0.001% gelatin. 
LTB 
10mM Tris/HCI pH 8.0; 1mM EDTA. 
20 x SSC 
0.3M Tr-sodium citrate; 3.OM NaCl. 
Phosphate buffer 
1 M Na2 HPO4 ; 1 M NaH 2 PO4 ; to give pH 7.2 
TFB (for Hanahans 
10mM K-MES; 100mM KCI 
Hexamine cobalt chloride. 
45mM MnCl2; 10mM CaCl2; 3mM 
TE (general) 
10mM Tnis/H Cl pH 8.0; 1mM EDTA 
TE (sequencing) 
10mM Tris/H Cl pH 8.0; 0.1mM EDTA 
TM 
100mM Tris/H CI pH 8.0; 50mM MgCl2 
5x MOPS buffer 
0.2M MOPS pH7.0, 50mM CH 3 COONa, 5mM EDTA pH8.0 
PIPES hybridization solution 
50mM PIPES, 100mM NaCl, 50mM NaH2PO 4 , 50mM Na2HPO4 
1 m EDTA, 5% SIDS. 
Guanidinium thiocyanate solution 
4M High purity guanidinium thiocyanate, 0.5% SDS, 25mM 
EDIA pH7.5, 0.13% antifoam A. pH adjusted to 7.0 with 1M NaOH 
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and filtered. f3-Mercaptoethanol added to final concentration of 
0.1M, and the solution filtered through 0.45jsm filter. 
Kienow mix 
0.4 units Kienow, 1j.tCi 35 S-dATP, in 10mM Tris/HCI pH8.0, 
10mM DIT, per tube. 
Formamide dye mix 
2mg xylene cyanol, 2mg bromophenol blue in lOmi delonised 
formamide, 10mM EDIA. 
ENZYMES 
Restriction enzymes were purchased from Boehringer 
Mannheim, Bethesda Research Laboratories, Pharmacia, and 
Northumbria Biologicals Ltd.; Klenow fragment and random primer 
labelling kit from Boehringer Mannheim, 14 DNA ligase from New 
England Biolabs. 
PRIMER 
M13-specific 17-mer sequencing primer was purchased 
from New England Biolabs, with the following sequence: 
5'- GTAAAACGACG000AGT -3' 
2.5 BACTERIAL STRAINS 
NM514 (hsd R, jy7) for growth of recombinant X N M 1 149 
(Murray, 1983). 
NM522 (Lac-px., hsd MS, F' lac ZM15, lac Tq ) for M13 phage 
growth. (Cough and Murray, 1983). 
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2.6 BACTERIOPHAGE STRAINS 
M13mp18 and M13mp19 (Yanisch-Perron eta!, 1985). 
?. GT10 (Huynh eta!, 1985). 
XNM 1149 (Murray, 1983). 
2.7 METHODS 
2.7.1 	Ornithine decarboxylase assay 
Chickens were weighed and killed by cervical dislocation. 
The breast muscle was then dissected out and excess fat and 
connective tissue removed. When less than 2 gm of muscle was 
present the whole muscle was used, otherwise a sample of about 
2 gm was removed for assay. 
In the case of embryo samples the whole embryo was used. 
Embryos were not pooled. Tissue samples were frozen in liquid 
nitrogen and stored at -70°C until use (storage for up to six 
months had no effect on enzyme activity) 
Tissue was homogenised with a polytron homogeniser in 5x 
w/v 0.1M phosphate buffer for 30 seconds. The homogenate was 
then spun in a MSE Chilspin centrifuge for 15 minutes at 3000xg. 
The supernatant was assayed in triplicate for ODC activity 
by the same procedure as described for histidine decarboxylase 
(Bulfield & Nahum, 1978; Martin et a!, 1984) in a reaction mix 
giving final concentrations of 0.1mM pyridoxal-5'-phosphate, 
1.0mM ornithine hydrochloride (containing approximately 16,000 
cpm L-[ 1- 14C] ornithine hydrochloride) and 1.0 mM potassium 
phosphate buffer pH 7.5. This was incubated at 30°C for 2 hours in 
a shaking water bath. 250j.xl of 10% TCA was then injected 
through the cap to stop the reaction and release the 14CO2 
liberated, and the caps immediately resealed. The 14CO2 was 
trapped in hyamine hydroxide soaked filter paper rolled up inside 
the caps. After incubating for a further 30 minutes, the filter 
papers were removed and counted in a scintillation counter. 
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The ODC activity is expressed as nmo1 14 CO2/min/gm wet 
wt. 
2.7.2 Preparation of DNA 
Preparation of plasmid DNA 
An overnight culture of plasmid was diluted 1:50 in L-broth 
plus 0.2% glucose and antibiotic for selection. This was incubated 
at 37°C overnight. Cells were killed with a few drops of 
chloroform and pelleted by centrifugation at 7000xg for 15 
minutes. The cells were resuspended in sucrose mix (25% sucrose, 
50mM Iris, 40mM EDTA ), 6mls/500m1s culture, and cell walls 
digested by adding imI of 10mg1mi lysosyme in sucrose mix. 
Addition of Triton mix (0.1% Triton X100, 52mM EDTA, 50mM Iris) 
caused cells to lyse. Lysate was centrifuged at 18000xg for 
30mins to pellet cell debris. The supernatant was banded on a 
1 .55g/ml CsCI equilibrium gradient plus ethidium bromide. The 
plasmid band was removed through the side wall of the tube with 
a needle and the ethidium bromide removed by isopropanol 
extraction. The DNA was then dialysed against TE overnight and 
ethanol precipitated. 
?. Plate lysates (adapted from Maniatis et a!, 1982) 
A single well-separated plaque was picked into 0.5ml phage 
buffer. 0.1ml was added to 0.2m1 plating cells and 2.5m1 BBL top 
agar for each plate. This was plated out onto fresh L-plates 
(generally 4 plates from each plaque), along with one plate of 
cells only for comparison. After incubation at 37°C for several 
hours, plaques became confluent and 4m1 L-broth was added to 
each plate. The plates were transferred to 4°C overnight and the 
phage harvested the following day by removing the L-broth and 
top layer into a sterile McCartney bottle, vortexing and 
centrifugation. The supernatant was decanted and a few drops of 
chloroform added to prevent any bacterial contamination. 
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X Liquid lysate (Maniatiset a!, 1982) 
Phage from plate lysates were added to 200ml of host 
strain (0D5400.5) to give a multiplicity of infection of 1. After 
shaking at 37°C for 2 to 3 hours, lysis was observed and 0.2ml 
chloroform was added to ensure complete lysis and release phage. 
Bacterial nucleic acids were removed by addition of DNase and 
ANase and the phage precipitated with PEG 8000. After 
centrifugation the phage were resuspended in phage buffer and 
banded on a CsCl step gradient (1.3, 1.5, and 1 .7g/ml CsCI). For 
preparation of vector DNA the phage were rebanded on a 1.5g/ml 
CsCI equilibrium gradient. Phage coats were removed with 
Proteinase K and DNA recovered by dialysis against TE and ethanol 
precipitation. 
2.7.3 	Preparation of cells 
Plating cells 
For plating A phage an overnight culture of host strain was 
diluted 1:20 and grown to 0D650 0.5. Cells were pelleted and 
resuspended in 1 /2 volume 10mM MgCl2. 
For M13 phage a fresh overnight culture of NM522 was used 
with X-gal and IPTG added to final concentrations of 2.5mg/mi, 
for visual identification of recombinant plaques. 
Competent cells (CaCl2 method) 
For rapid transformation of pUC or M13 into NM522 the 
following method was used; 
An overnight culture of NM522 was diluted 1:50 with L-
broth and grown to 0D6 50 0.45. Cells were pelleted in a Chiispin 
benchtop centrifuge and resuspended in 1/2 volume 50mM Ca C1 2 . 
After leaving on ice for 15 minutes the cells were pelleted again 
and resuspended in 1 /10 volume 50mM Ca C12 and kept on ice until 
used. 
Competent cells (Hanahan, 1983) 
When a more efficient transformation with M13 was 
required competent cells were prepared by the following method; 
A 1:100 dilution of NM522 was grown to 006500.6, placed on 
ice for 1 hour, pelleted and resuspended in 1/3  volume TFB. After 
a further 10-15 minutes on ice, the cells were pelleted again and 
resuspended in 1 /125 volume of TFB plus 7jsl of DMSO/200R1 cells. 
After 5 minutes 7R1 DTT (2.25M in 40mM potassium acetate) 
' 200 R 1 cells was added, and after a further 10 minutes, DMSO 
added as before. Cells were kept on ice throughout. 
2.7.4 DNA manipulation 
Transformation 
For transformation of M13, 200p.l  of competent cells was 
added to 5ng DNA in 50ml TCM. After leaving on ice for 30 
minutes the cells were heat shocked at 42°C for 2 minutes then 
replaced on ice for 15-20 minutes before plating onto minimal 
plates with plating cells and BBL top agar. The procedure was the 
same for pUC with the addition of imI L-broth and incubation at 
37°C for 1 hour immediately before plating. Cells were plated by 
spreading 0.1ml onto minimal plates. 
DNA restriction 
DNA restrictions were carried out at 37°C using high, 
medium, or low salt buffers. Volume of enzyme used was always 
<10% of total reaction volume. Digestion was stopped by phenol 
extraction and ethanol precipitation. 
Ligation 
Vector and donor fragments were incubated in the presence 
of 100 units T4 ligase at 14°C overnight or 25°C for 2 hours in 
ligase buffer to give a total volume of 10121. 
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Agarose gel electrophoresis 
Electrophoresis 	of DNA 	was 	generally 	though 	0.7-1.0% 
agarose for 3 hours at boy or overnight at 20V, in TAE or TBE 
buffer. 	Preparative 	gel electrophoresis was 	in 	1.2-1.5% low 
melting 	point 	ultrapure agarose at 20V overnight. 	Gels were 
stained 	with 	ethidium bromide 	and viewed 	on 	a UV 
transilluminator. 
Purification of DNA from gels 
Fragments were separated by gel electrophoresis in TAE 
buffer and the appropriate band excised from the gel. The DNA 
was extracted using a BIO 101 inc. "Geneclean" kit, supplied by 
Strathtech Scientific Ltd., London, according to the 
manufacturers instructions, which routinely gave recovery of 75-
85% of the DNA. 
2.7.5 Preparation of RNA 
Isolation of RNA 
RNA extraction was by modification of the procedure 
described by Chirgwin et a!, (1979). Tissue was dissected out 
into guanidinium thiocyanate solution (7.5mg/mi) on ice. This was 
then homogenised and centrifuged to remove particulate material. 
The supernatent was removed and spun through a 5.7M/2.4M CsCl 
step gradient. This pellets RNA greater than 9.7S. The RNA pellet 
was then resuspended in 10mM Tris/HCI, 1mM EDTA, 5% SDS, 5% 
phenol. After addition of NaCl to a final concentration of 0.1M, 
any denatured ribonuclease was removed by phenol/chloroform 
extraction. The RNA was ethanol precipitated and resuspended in 
DEP treated dH20. 
All solutions were prepared in DEP treated dH20 and 
glassware baked before use. 
Purification of Poly (At) RNA 
A column was prepared from oligo (dT)-cellulose and 
washed with 5 volumes of 0.1M KOH and 10 volumes of application 
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buffer (0.5M KCI, 0.01M Tris/HCI pH7.5). The RNA was heat 
denatured and cooled on ice before loading on the column in 
application buffer. The column was washed twice with 
application buffer and twice with 0.1M KCI, 0.01M Tris/HCI pH7.5. 
Poly (A+) ANA was eluted in 0.01M Tris/HCI pH7.5. Purity of the 
RNA could be increased by repeating this procedure. 
Gel Electroohoresis of RNA 
Electrophoresis of RNA was in 1.2% agarose in 1xMOPS, 
0.75% formaldehyde. 45ji1 of sample was loaded consisting of 
10.1gl RNA in dH20, 4.5p1 5xMOPS, 7.9.tl 37% formaldehyde, 
225R 1  formamide. This was heated to 55°C for 15 minutes and 
cooled on ice to denature the RNA, then 5pi of formamide dye mix 
added before loading. The gel was run at 100V for 3-4 hours or 
30-40V overnight. 
2.7.6 	Blotting and hybridization procedures 
Southern Blotting (Smith and Summers, 1980) 
After electrophoresis, the gel was depurinated in 0.25M HCI 
for 15 minutes, denatured in 1.5M NaCl, 0.5M NaOH for 30 minutes 
and neutralised in 1M NH4 acetate, 0.02M NaOH for 1 hour. The gel 
was then inverted onto a glass plate and nitrocellulose or nylon 
"Hybond" filter placed on top, followed by 3 sheets of Whatman 
3MM filter paper soaked in 1M NH4 acetate, 0.02M NaOH. About 
2cm of dry blotting paper was placed on top of this and a stack of 
dry paper towels. A glass plate and weight were place on top to 
ensure even pressure. Transfer was allowed to proceed overnight 
then the filter removed and rinsed in 2 x SSC and baked at 80°C 
under vacuum (nitrocellulose) or the DNA bound on a 
transilluminator for 7 minutes (nylon). 
Plaque lifts 
Plaques to be screened were transferred to nitrocellulose 
discs by placing them on top of the plates for 1-2 minutes. The 
discs were soaked in 0.5M NaOH, 1.5M NaCl to denature the DNA 
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then neutralised in 0.5M Tris, 3.OM NaCl, pH7.0, and rinsed in 2 x 
550 before baking at 80°C under vacuum. 
Radiolabelling DNA probes (Feinberg and Vogelstein, 1983) 
The DNA to be labelled was restricted and separated on an 
agarose gel, then the required fragment excised from the gel and 
placed in a preweighed 1.5m1 microcentrifuge tube. Distilled 
water was added to a ratio of 3ml/g gel, boiled for 7 minutes to 
dissolve the agarose and denature the DNA, and stored at -20°C 
until used. The gel was reboiled for 3 minutes before subsequent 
labelling. Labelling was at 37°C using the Boehringer Mannheim 
random primed DNA labelling kit. 25ng of DNA was used and the 
reaction allowed to continue for 30 minutes before termination 
by addition of lOOl.tl hybridization solution (see below) at 65°C. 
Hybridization of Southern blots or plaque lifts 	(Church and 
Gilbert, 1984). 
Prehybridization was for 1 to 2 hours in a 50:50 mixture of 
14% SDS and 1M phosphate buffer pH 7.4 at 50-65°C depending on 
stringency required. Hybridization in fresh solution plus heat 
denatured probe (10 minutes at 95-100°C) was carried out 
overnight at the same temperature. Filters were washed in 
SDS/phosphate buffer for 2 or 3 x 20 minutes. 
Northern Blotting 
Transfer of RNA was done using an LKB 2016 VacuGene 
vacuum blotting system. Nylon filter was cut slightly larger than 
the gel and placed on the apparatus, with a polythene mask on top, 
the window being slightly smaller than the gel. The gel was 
placed on top of this forming a seal. Transfer solution (lOx SSC) 
was poured on top to cover the gel and the vacuum applied to the 
apparatus. Transfer was carried out for 30-60 minutes. 
Hybridization of Northerns 
The probe was labelled in the same way as for Southerns. 
Filters were prehybridized in PIPES hybridization solution for 30 
minutes. The solution was changed, denatured probe added and the 
we 
filter hybridized overnight at the required temperature. Washing 
was 2x 15 minutes in lx SSC, 5% SIDS. 
Autoradiography 
Autoradiography was at -70°C with intensifying screens 
with exposure varied depending on the strength of the signal. 
2.7.7 Sequencing methods 
M13 Sequencing templates (Sanger et a!, 1980) 
A fresh 	overnight, culture of NM522 was diluted 1:40 	in 	L- 
broth and grown to 0D65 0 0.3. Single M13 plaques were picked into 
1 ml aliquots 	of culture and shaken at 37°C for 4 1 /2 hours. The 
cells were 	then pelleted 	in 	a 	microcentrifuge 	and the 	phage 
precipitated from the supernatant with PEG 6000. The precipitate 
was resuspended in TE and the phage coats removed by vortexing 
with phenol. The DNA was ethanol precipitated and resuspended in 
40 R1 TE. 
Sequencing 
8pl of each template was mixed with ijil primer plus 1R1 
TM and incubated at 60°C for 1 hour to anneal the primer. This 
was then dispensed in 2 j.ii aliquots into capless microcentrifuge 
tubes and 2g1 of either G, A, T, or C termination mix added (see 
below) plus 2iil of Klenow mix. After 20 minutes at room 
temperature, 2j.il of chase (0.25M dGATC) was added and the tubes 
incubated for a further 20 minutes. The samples were stored at - 
20°C until use. Before loading on the gel, 2pi formamide dye mix 
was added and the samples boiled for 3 minutes to denature the 
DNA. 
Termination mixes 
Each template was sequenced using each of four termination 
mixes, ci, A, T, C, containing the three deoxynucleotides plus the 
appropriate dideoxynucleotide. The ratio of dideoxy- to 
921 
deoxynucleotides was varied depending on the length of run to 
ensure termination occurred within the range of the gel. 
Extended DNA sequencing 
When sequencing of longer fragments of DNA was required, 
(up to 600bp) the 'Sequenase' kit (United States Biochemical 
Company) and recommended protocol were used. 
Polvacrylamide sequencing gel (Biggin et a!, 1983) 
Gel electrophoresis of sequencing samples was on either a 
0.5/2.5 TBE buffer gradient 6% acrylamide gel (short runs, 3-4 
hours) or a 6% acrylamide gel with no buffer gradient (long runs 
6-9 hours), at 35-40 watts. The gel was fixed in 10% acetic acid, 
10% methanol, transferred to blotting paper and dried down 
before autoradiography. 
Sequence data analysis 
Sequence data was compiled and analysed using the 
University of Wisconsin Genetics Computer Group sequence 
analysis software package (Devereux et a!, 1984) 
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Genetic improvement of meat production in animals is 
usually by selection for growth or increased weight-for-age and, 
more recently, food conversion efficiency. In poultry, classical 
breeding and selection techniques have produced animals which 
differ greatly in body weight and muscle weight. The most 
divergent lines can differ up to four fold in body weight and 
between 4 and 8 fold in muscle weight at 7 weeks of age. 
Although it is not known which aspects of cellular growth have 
been altered in these selected lines, they provide a useful 
experimental model for studying the genes involved in growth. 
At hatch there is little or no difference in body weight 
between broiler and layer lines, however by one week of age the 
difference is already apparent. Body and muscle weight are 
significantly greater in broiler chicks and development is more 
advanced (eg. appearance of wing feathers). Studies on hormones 
potentially involved in altered growth rate have shown similar 
plasma IGF-1 and lower plasma growth hormone concentrations in 
faster growing lines at this age. So although increases in plasma 
IGF-1 and growth hormone accompany periods of rapid growth 
within a line, no positive correlation to increased growth in 
selected lines has been shown (Burke & Marks, 1982; Goddard et 
a!, 1988). 
Ornithine decarboxylase in chickens has been measured in 
several tissues. At hatch liver ODC activity is high and decreases 
rapidly in the first three weeks, but there are no significant 
strain differences. The same is true for ODC activity in kidney. 
cr2- 
Muscle ODC activity however, peaks at 5-6 days post-hatch and 
can be up to 20 fold higher in selected broiler lines than in layers 
unselected for growth. (Bulfield et a!, 1988). This difference in 
peak ODC activity immediately precedes the period of most rapid 
growth in both strains. 
High levels of ODC have also been demonstrated in embryos, 
both in chickens .(Lowkwist eta!, 1985) and in mammals (Fozard 
et a!, 1980). The peak of ODC activity in chick embryos is at 4-5 
days, and in mouse and rat at about 12 days, which corresponds to 
mid-organogenesis in each case. Inhibition of polyamine synthesis 
at this stage has been shown to inhibit further development of 
the embryo (Fozard et a!, 1980; Lowkwist et a!, 1983). 
Although ODC activity has been measured in chick embryos 
at every stage of development, the possibility of variation in ODC 
correlated with differences in growth rate has not so far been 
investigated. 
The initial experiments were therefore designed to confirm 
the difference in post-hatch muscle ODC activity in the broiler 
and layer strains to be used in these studies. The next stage was 
to try to inhibit the peak in ODC activity at 5-6 days and examine 
the effect on body weight and muscle growth. In addition to this, 
ODC activity was measured in broiler and layer embryos to 
discover if the differences between selected and non-selected 
lines found in post-hatch muscle were also present in embryonic 
development. 
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3.2 MUSCLE ORNITHINE DECARBOXYLASE ACTIVITY. 
ODC activity was measured in breast muscle and the muscle 
weight recorded in 10 animals from lines 101 (broiler) and 71 
(layer) at 6 days post-hatch. Breast muscle mass was two fold 
higher in broilers (2.21±0.11g) than in layers (1.12±0.09g) and the 
mean ODC activity was almost four fold greater (0.63±0.03 in line 
101; 0.16±0.02 in line 71). Although ODC activities found in 101 
broiler muscle are similar to those previously reported, the 
difference in activities between broiler and layer is considerably 
less. However the strain of layer used in this study, line 71, is a 
heavier-bodied strain than used in the previous experiments and 
this seems a likely explanation for the higher ODC activities 
found here than in the previous study (Bulfield et a!, 1988). 
3.3 EFFECT OF ct-DIFLUQROMETHYLORNITHJNE. 
To investigate the effect of inhibiting the peak in ODC 
activity in the first week of growth, a-difluoromethylornithine 
(DEMO) was used. This is a specific, irreversible inhibitor of ODC. 
By inhibiting ODC activity at this stage it was hoped that a causal 
relationship could be established between ODC and growth. 
The animals used were Line 101 broiler chicks., Since 
muscle ODC activity is high in these animals at this stage, it 
should be easier to evaluate the effect of inhibiting the enzyme. 
50 chicks were obtained at one day old, and divided at 
random into two equal groups. Food and water were unrestricted 
LA SLIS 
throughout the experiment. At day 4 all the animals were weighed 
and one group was given DFMO (2% in the drinking water) for the 
following four days. At day 8 DFMO treatment was withdrawn and 
all the animals weighed again. Also at day 8, seven animals from 
each group were killed and breast muscle dissected out to assay 
for ODC activity. At day 15 the remaining animals were weighed 
again, and a further seven from each group killed and breast 
muscle removed. This procedure was repeated at day 49. Food and 
water intake of both groups was measured from day 4 to day 8, to 
try to account for any other factor which might have affected the 
growth rate. 
RESULTS. 
The body weight of the DFMO-treated and control groups was 
significantly different at only one point measured (see Table 3.1), 
this being at day 8, immediately after treatment. At this stage 
the treated group were, on average, 10 grams lighter than the 
control group. After a further seven days, without DFMO, this 
difference has been eliminated (day 15). 
Since the DFMO was given in the drinking water, a decrease, 
in water intake would be expected if the taste of DEMO affected 
appetite. This however was not the case, and water intake 
between day 4 and day 8 was found to be the same for both 
groups. Food intake was also measured for each group as a whole 
(Table 3.2). During treatment with DFMO the food consumption of 
the experimental group was lower than that of the control group. 
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TABLE 3.1 Total body weight of DFMO treated and control birds. 
mean ± s.e.m., n=7) 
TABLE 3.2 Food intake of DFMO treated and control birds as a 
function of body weight. 
BODY WEIGHT (g) 
day 	day 	day 15 
	
day 49 





±1.68 ±4.76 ±45.2 
Control 	68.3 
	
99.7 	218.0 	1721 
	
±1.52 ±2.55 ±7.74 ±58.8 
FOOD INTAKE (g)/GRAM BODY WT 
days 1-4 	J days 4-8 	J days 8-15 
DFMO 	 I 
Treated 0.35 	 0.53 	I 	0.91 
Control 1 	0.36 	1 	0.63 	j 	0.95 
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At all other points measured the food intake of both groups was 
the same. It could be argued that the growth rate of the DFMO 
treated birds is reduced because their food intake is lower as a 
result of general toxicity of DFMO, or purely because it is 
unpalatable. However, if the latter argument was true, water 
intake would also be expected to decrease, which it does not. It 
seems likely that the experimental group are eating less because 
they are smaller, rather than reduced food intake being solely 
responsible for reduced growth rate. 
Table 3.3 shows the muscle ODC activities at days 8, 15 and 
49. Although the mean value for the control group at day 8 is 
almost twice that of the treated group, this is not statistically 
significant because of the high variation in activity found in 
muscle from the controls. The only point at which the ODC 
activity is significantly different (pc0.05) between the two 
groups is at 49 days when the muscle ODC activity of the treated 
animals is higher than in the control group. 
Breast muscle weight of the treated birds is lower than the 
controls at every age measured but is not significant at the 5% 
level (Table 3.4). 
Further experiments are necessary to clarify the effects 
found here. It seems that a different approach would be needed to 
fully establish a causal effect between ODC activity and growth, 
and to overcome the argument of general toxicity of DFMO. 
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TABLE 3.3 	Ornithine decarboxylase activity in breast muscle of 
DFMO treated and control birds. 
Activity expressed as nmo1 14 CO2 Imin/g wet wt. 
(mean ± s.e.m.,n=7 ). 
TABLE 3.4 Total breast muscle weight in DFMO treated and 
control birds 
mean ± s.e.m., n=7 ). 
ODC ACTIVITY ( nmol 'tO2 /miri/g wet WI) 
Day 8 	 Day 15 	Day 49 
DEMO 	0.18 	 0.16 	 0.040' 
Treated ±0.02 	 ±0.02 	 ±0.006 
Control 	0.35 	 0.18 	 0.021 
±0.13 	 ±0.04 	 ±0.005 
MUSCLE WI (g) 
Day 8 	 Day 15 	Day 49 
DFMO 	1.90 	 5.99 	 125.9 
Treated ±0.14 	 ±0.37 	 ±8.7 
Control 	2.14 	
7.21 	 139.1 
	
±0.31 ±0.56 	 ±15.0 
3.4 EMBRYO ORNITHINE DECARBOXYLASE ACTIVITY. 
ODC activity was measured in whole embryos from day 4 to 
day 7 (in the case of lines ATF and MC ) or day 3 to day 7 (lines 71 
and 101). Activity at day 3 was measured in lines 71 and 101 
because the activity decreased from day 4 and it was necessary 
to discover if this was the highest point. 
The next step was to try to localise the site of ODC activity. 
At four days it would be extremely difficult to assay for the 
enzyme activity in specific regions of the embryo, so the embryos 
were dissected as accurately as possible into head and body 
regions. ODC activity in the head region is thought to influence 
central nervous system development whereas in the body region it 
is likely to be involved in the growth of muscle, vascular system 
and peripheral nervous system. 
Enzyme activity was measured in seven embryos at each 
age. The embryos were killed at the same time each day and 
frozen immediately in liquid nitrogen. This was found to have no 
effect on measured ODC activity. 
Lines MC and ATF were used initially for this experiment 
but lines 71 and 101 were used subsequently as these were to be 
more readily available for further experiments. 
RESULTS. 
It can be seen from Fig.3.1 that ornithine decarboxylase 
activity peaks at day 5 in both ATF and MC embryos. Activity in 
the broiler (MC) embryos was significantly higher than in the 
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FIGURE 3.1 Ornithine decarboxyfase activity in 4 to 7 day embryos; 
lines MC and ATF 
Activity expressed as nmol 14 CO 2 /min/g wet wt. 
mean ± s.e.m, n=7). 
FIGURE 3.2 Total embryo weight of 4 to 7 day embryos; lines MC and 
ATF 
mean ± s.e.m., n=7). 
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layers (ATF) at both day 5 (p.c0.01) and day 6 (pc0.05). At day 5 
the difference was almost two fold. By day 7 there was no 
significant difference in activity between the two lines. 
Between 4 and 7 days the embryos are growing extremely 
rapidly. Embryo weight at day 7 was 12 times weight at day 4 in 
both lines (Fig .3.2). At day 4 and 5. there was no difference 
between the two lines, but by day 6 the MC embryos were 
significantly heavier than the ATF embryos (pc0.001). and this 
difference increased at day 7. This period of faster growth in the 
broiler (MC) line occurred immediately after the peak in ODC 
activity which was two fold greater in line MC. 
In lines 71 and 101, ODC activity peaked at day 4 (see Fig. 
3.3). At day 3 there was no difference in activity, but at day 4 
line 71 had significantly higher ODC activity than line 101 
(pc0.001). By day 6 this difference had been eliminated. At the 
peak value, the enzyme activity in line 71 (layer) embryos was 
about 1.5 times that in line 101 (broiler). 
In this case, the peak ODC activity was greater in the layer 
line (71) than in the broiler (101), and this was reflected in the 
differences in embryo weight (Fig 3.4). Up to day 5 there was no 
difference in weight, but by 6 days - again immediately after the 
peak in 000 activity - line 71 embryos were significantly heavier 
than line 101 (pc0.001). This time however the weight difference 
disappears by day 7. 
Measurement of weight and ODC activity in head and body 
regions was also done using line 71 and line 101 embryos. In both 
strains the head region of the embryo is heavier than the tail 
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FIGURE 3.3 Ornithine decarboxylase activity in 3 to 7 day embryos; 
lines 71 and 101 
Activity expressed as nmoI 14 002 /min/g wet wt. 
mean ± s.e.m.,n=7 ). 
FIGURE 3.4 Total embryo weight of 3 to 7 day embryos: lines 71 
and 101 
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FIGURE 3.5 Weights of separate head and body regions of 4 to 7 day 
embryos; lines 71 and 101 
mean ± s.e.m, n=7 ). 
h = head 
t = body 
n=7 
FIGURE 3.6 Ornithine decarboxylase activity in head and body regions 
of 4 to 7 day embryos; lines 71 and 101. 
Activity expressed as nmo1 14 CO2 /min/g wet wt. 
mean ± s.e.m., n=7). 
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region at 6 and 7 days (Fig 3.5 ). This difference is most marked 
in line 71 (p=0.01) and is enough to account for the difference in 
total embryo weight at this stage of development. 
Because of the small amount of tissue used for these 
experiments, the errors involved in the measurements of ODC 
activity were high. However, it can be seen from Figure 3.6 that 
the differences in ODC activity in the head and body regions of the 
embryos were consistent with the differences in weight. It can 
also be seen that the difference in ODC activity between the two 
lines is mainly due to the high activity found in the head region of 
the line 71 embryos. 
3.5 DISCUSSION. 
The involvement of ornithine decarboxylase and the 
polyamines in cell proliferation has been well documented 
(reviews; Heby, 1981; Pegg & McCann, 1982; Tabor & labor, 
1984), however its exact role is still to be established. High 
levels of ODC have been reported in many situations where cells 
are 	known to 	be 	dividing 	rapidly, 	e.g. in 	embryonic growth, 
regenerating liver, and in response to known mitogens. 
A previous study (Bulfield 	et a!, 	1988) has demonstrated the 
possible 	involvement of ODC 	in 	selection for increased growth. 
Twenty fold higher 	muscle 	ODC 	activity was found 	in broilers 
selected for increased growth and muscle weight, 	than 	in 	layers 
at one week of age. By seven weeks the broilers had 8 fold greater 
muscle mass and were 4 fold heavier than the layers. 
By inhibiting ODC activity at this stage, it was hoped that 
an effect on muscle growth and body weight would be seen. The 
results show that, although the mean ODC activity in the treated 
birds immediately after treatment is only half that of the 
controls, the difference is not significant because of the high 
variation found in the controls. This observation itself could be a 
result of DFNO treatment. It is possible that treatment with DEMO 
eliminates the variation in activities in the treated birds. The 
most important observation is that both muscle weight and body 
weight are lower in the experimental birds after treatment. 
It could be argued that DFMO has a general toxic effect 
which would cause decreased growth. This is an extremely 
difficult argument to overcome. However, it can be pointed out 
that DFMO is a specific inhibitor of ODC, that the birds continued 
to eat and drink throughout the treatment, and that the effects 
(lower body and muscle weight) were not permanent. 
This experiment was limited by the amount, of DFMO 
available. Ideally, a larger number of birds would be used and, 
because ODC activity has already started to rise at four days, the 
treatment started at 2 or 3 days post-hatch. It would also be 
useful to measure muscle weights and ODC activities during, as 
well as after treatment. 
It can therefore be concluded from these results that 
although the association between ODC activity and growth is 
clear, this experiment is not able to establish conclusively a 
causal relationship, and a different approach would be necessary 
to overcome the argument that DEMO is generally toxic to the 
animals. 
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Evidence that there is a peak in ODC activity in chick 
embryos at about 5 days made this a good starting point to look 
for differences between lines. The first two strains showed a 
clearcut difference in activity at four days; the broiler strain 
(MC) having 2 fold higher peak activity than the layer (ATE). Lines 
71 and 101, however, gave what seemed to be a conflicting result. 
The layer strain (71) in this case showed higher peak activity 
than the broiler (101). But when the embryo weights of each 
strain are taken into account, it can be seen That in each case the 
strain with the higher ODC activity was also the faster growing 
strain at this stage. The most significant feature of these results 
is that in all four strains the peak in ODC activity is followed 
immediately by a period of very rapid growth, and the strains 
with the higher peak activity have significantly higher embryo 
weights immediately after this peak. 
It is also interesting that the high ODC activity and weight 
in line 71 can be isolated to the head region of the embryo and are 
therefore likely to be due to CNS development. Previous reports 
support this finding. Using immunofluorescence both ODC protein 
and catalytically active ODC in '2 day chicken embryos were 
shown to be present mainly, but not exclusively, in the brain 
(Lowkvist et a!, 1985; 1987). 
These results indicate that ODC in the embryo at this stage 
is mainly involved in CNS development, although it is undoubtedly 
present in other tissues as well. It is clear that ODC is related to 
embryo growth as empirically determined, but (in the case of 
lines 101 and 71 ) it is probably not related to the potential for 
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post-natal growth. In every case studied here, both in embryos 
and post-hatch birds, increased growth rate was associated with 
increased - ODC activity. 
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CHAPTER 4 
CLONING OF PUTATIVE CHICKEN ORNITHINE 
DECARBOXYLASE cDNA AND INVESTIGATION OF 
ORGANISATION AND EXPRESSION OF THE GENE 
15-8 
4.1 INTRODUCTION 
An interesting feature of ornithine decarboxylase is its 
ability to respond very rapidly to the many factors which 
influence its activity. The enzyme shows rapid induction kinetics 
and an extremely short half life of about 10-15 minutes. (Kahana 
& Nathans, 1984; Pegg & McCann, 1982). Regulation of the enzyme 
has been shown to be due to changes in protein stability, 
transcription and translation rates, and mRNA half life, as well 
as gene amplification and the action of an 'antizyme' (Canellakis 
et a!, 1981; McConlogue & Coffino, 1983a&b; McConlogue et a!, 
1986; Murakami eta!, 1988; Seely & Pegg, 1983). 
Studies of these mechanisms in mouse and rat have been 
facilitated by the cloning of the cDNAs for both these species 
(Kahana & Nathans, 1984; Van Kranen et a!, 1987). This has also 
allowed the organisation of the gene to be studied, showing a very 
complex picture. In both mouse and rat, there are 12 exons 
separated by 11 introns (see Fig 4.1) and the gene spans about 7-
8kb (Coffino & Chen, 1988; van Steeg et a!, 1988). Southern blots 
have demonstrated the presence of multiple pseudogenes in both 
species, with probably only one of these being a functional 
structural gene. 
In humans the picture seems to be somewhat simpler. The 
cDNA for human 000 has been cloned (Hickok et a!, 1987) and 
information gained using this as a probe to genomic DNA suggests 
that there are probably only two genes in the ODC family in 
FIGURE 4.1 ORGANISATION OF THE ODC GENE IN MOUSE AND RAT 
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humans, and not the large number found in mouse and rat 
(Winqvist at a!, 1986). 
Expression of ODC also differs between mouse/rat and 
humans. In the mouse, two mRNA species of 2.2kb and 2.7kb have 
been detected (Kontula et a!, 1984 ). The rat also expresses two 
mRNAs, 2.1 kb and 2.6kb in size (van Kranen at al, 1987). In human 
cells however, there appears to be only one of about 2.25kb 
(Hickok et a!, 1987 ). 
Using a mouse cDNA probe, the aim was to isolate a chicken 
ODC cDNA and use it to investigate the organisation of chicken 
genomic ODC and expression of the mRNA. Continuing from the 
results discussed in chapter 3, the best stage to look at ODC 
expression seemed to be at 4-5 days in embryos and at 6-7 days 
in post-hatch muscle. It would be interesting to see if the 
differences in activity between strains were due to differences 
in gene expression. Also, bearing in mind the complex 
organisation of the ODC gene in mouse and rat, and the somewhat 
simpler situation in humans, does chicken ODC also belong to a 
multigene family, and how many RNAs are expressed ? 
We were given two plasmids containing mouse ODC cDNA; 
pOD54, from Professor 0. A. Janne, The Population Council, Center 
for Biomedical Research, New York, USA; and p0D65 from Dr L 
Sanders, John Hopkins University School of Medicine, Baltimore, 
USA. 
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4.2 PROBING OF SOUTHERN BLOTS WITH MOUSE ODC cDNA. 
Before screening a cDNA library, Southern blots of chicken 
genomic DNA were probed with mouse ODC cDNA to see if any 
cross hybridization could be detected. Southern blots were 
originally probed with a 630bp Hhal insert from plasmid pOD54 
(Kontula et a!, 1984; see Fig 4.2a). The results obtained with this 
probe were inconclusive. It hybridized to multiple bands in the 
mouse DNA, but no bands could be detected in the chicken DNA 
except at very low stringency. 
When a plasmid map was constructed using the UWGCG 
package (Devereux et a!, 1984) it could be seen that although the 
insert was approximately 750bp long, less than half of this was 
coding region of the cDNA. 
Another probe was then constructed from plasmid pOD65 
(Kahana & Nathans, 1985), by partial digest with Pstl to produce a 
1330bp fragment which was separated from the vector by agarose 
gel electrophoresis. The fragment contained most of the coding 
region and only a small amount of 3' non-coding sequence (see Fig 
4.2b). This probe hybridized to multiple bands (at least eight) in 
mouse genomic DNA, as expected, and also weakly to several 
bands in the chicken DNA - probably four or five (Fig 4.3). 
From these initial results it was concluded that the ODC 
cDNA from mouse cross-hybridized weakly with the ODC gene in 
chicken, and that the sequence was likely to be fairly well 
conserved. Also from the appearance of multiple bands in the 
chicken genomic DNA it looked as if the ODC gene in chickens 
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FIGURE 4.2a Plasmid p0D54 
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FIGURE 4.3 SOUTHERN BLOT OF CHICKEN AND MOUSE 
GENOMIC DNA PROBED WITH MOUSE ODC cDNA 
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Lane 1. and 5: Marker DNA 
Lane 2: C57B1/6J DNA digested with EcoRl. 
Lane 3: Broiler (101) DNA digested with EcoRl. 
Lane 4: Layer (71) DNA digested with EcoRl. 
Hybridization conditions: 0.5M Phosphate buffer pH 7.2, 7% 
SOS at 58°C for 18hrs. 
might belong to a multigene family, similar to the organisation 
found in mouse and rat. 
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4.3 ISOLATION OF CHICKEN ODC cDNA AND GENOMIC 
CLONES. 
A chicken cDNA library was screened with the same pOD65 
fragment as was used for Southern blots. The library was the gift 
of Dr H. Sang, (l.A.P.G.R.), and was made from mRNA from 4 1 /2 day 
layer embryos then inserted into XGT10 with EcoRl linkers. Over 
500,000 recombinants were screened and 14 clones which 
hybridized strongly to the mouse cDNA were picked. 
All 14 positives were subcloned into pUC18 and M13mp18. 
They were then digested with EcoRl and sized by agarose gel 
electrophoresis. Of the 14 positive clones isolated, 10 had a 
single insert of 1.7kb. The remaining 4 had inserts of between 
0.5kb and 1.3kb. Sequencing and restriction analysis of the 
largest cDNA (ODC13) are discussed in Chapter 5. 
Preliminary sequence analysis showed that clone ODC13 
was about 75-80% homologous to the published sequence of the 
human ODC cDNA. This seemed to be good evidence that ODC13 did 
indeed code for chicken ornithine decarboxylase, and also, judging 
from the fact that 14 positively hybridizing clones were isolated 
from screening 500,000 recombinants, ODC is expressed at a 
fairly high level in 4 1 /2 day embryos. 
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pOD65 was also used to screen a chicken genomic Hindill 
library (the gift of Dr. D. Fawcett, I.A.P.G.R.). Three positive 
clones were detected, one of which had two inserts. The inserts 
were 0.7kb, 1.5kb, 3.4kb and 3.8kb in size. These were subcloned 
into pUC18 and M13mp18 for sequencing and further analysis. 
Preliminary sequencing data from the two largest clones showed 
no significant homology to the known ODC sequences, so it was 
concluded that the regions sequenced were probably intron 
regions. It was at this point that the cDNA clones were obtained, 
so it was decided to concentrate on sequencing of those, and no 
further analysis was done on the genomic clones. 
4.4 PROBING OF SOUTHERN BLOTS WITH ODC13. 
The 1.7kb insert ODC13 was excised from pUC18 by 
restriction with EcoRl and separated from the vector on a 1.3% 
low melting point agarose gel. The fragment was radiolabeled by 
random priming and used to probe Southern blots of mouse and 
chicken genomic DNA (Figure 4.5, probe 1). 
The results obtained using the whole probe were fairly 
complex (Figure 4.4). A Hindill digest of genomic DNA probed with 
00013, showed three bands in all the lines used; 71, 101, and GL. 
These bands totalled approximately 7.5kb in size. When the 
genomic DNA was digested with Haelll, an enzyme with a 4bp 
recognition site, two bands of around 1.6 and 3.0kb were detected 
with probe 1. However in the broiler (101) DNA there was also a 
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FIGURE 4.4 SOUTHERN BLOT OF CHICKEN AND MOUSE 
GENOMIC DNA PROBED WITH ODC13. 
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Lane 1 and 2: Layer (71) DNA. 
Lane 3 and 4: Layer (GI) DNA. 
Lane 5 and 6: Broiler (101) DNA. 
Lane 7 and 8: C57B1/6J DNA. 
Lane 9 and 10: DBAI2J DNA. 
The DNA in lanes 1, 3, 5, 7, and 9 was digested with 
HindIll, and in lanes 2, 4, 6, and 8 with HaeIlI. 
Hybridization conditions: 0.5M Phosphate buffer pH 7.2, 7% 
SDS, at 63°C for 18hrs. 
FIGURE 4.5 CONSTRUCTION OF PROBES FROM ODC13 
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third band at about 2.9kb which was not present in the DNA from 
either of the two layer lines. 
In Figure 4.4 some bands were also visible in the mouse 
DNA. As would be expected, these were not as strong as the bands 
in the chicken DNA, but it would appear that there are multiple 
bands in mouse genomic DNA that hybridize to ODC13. 
The next step was to discover what area of the chicken gene 
was responsible for the polymorphism in the broiler DNA. To do 
this, two probes were constructed from ODC13 (see Figure 4.5). 
Probe 2 was a 700bp, EcoRl/Hindlll fragment from the 5' end of 
the cDNA. Probe 3 was from the 3' end and was constructed by 
digestion with BamHI and EcoRl to give a 600bp fragment. The 
fragments were separated from the vectors and remaining cDNA 
by electrophoresis before radiolabeling. 
Probe 2 (5' end) detected fewer bands than the whole cDNA, 
as expected, and the same bands were seen in all three lines. 
Hybridization with probe 3 (3' end) resulted in the same extra 
band lighting up in the broiler (101) DNA as had been seen when 
probing with the whole of ODC13 (Figure 4.6). Each of these bands 
was estimated to be about half the intensity of the corresponding 
single band in the layer (71, GL) lines. So the extra band in 101 
genomic DNA which hybridizes to ODC13 is due to a difference at 
the 3' end of the gene. 
It also seems from the results obtained with the whole 
probe and the 3' and 5' end probes, that there is probably only one 
ODC gene in the chicken. Unfortunately it is very difficult to 
prove this beyond doubt. The fact that the sizes of the hybridizing 
FIGURE 4.6 SOUTHERN BLOT OF CHICKEN GENOMIC DNA 
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Lane 1 and 2: Broiler (101) DNA. 
Lane 3 and 4: Layer (71) DNA. 
Lane 5 and 6: Layer (GI) DNA. 
The DNA in lanes 1, 3, and 5 was digested with Hindlil, in 
lanes 2, 4, and 6 with HaelIl. 
Hybridization conditions: 0.5M Phosphate buffer pH 7.2, 7% 
SDS, at 63°C for 18hrs. 
bands in the HindlIl digest add up to about 7.5kb (similar to the 
size of the mouse and rat genes), and that different bands 
hybridize to 3' and 5' ends of the cDNA, provides good evidence 
however that the pseudogenes found in mouse and rat are not 
present in the chicken genome. 
4.5 EXPRESSION OF ORNITHINE DECARBOXYLASE IN MUSCLE. 
The clone ODC13 was also used as a probe to look at ODC 
expression in 6 day post-hatch muscle. The whole of the cDNA 
was used as a probe to total, poly(A)+, and poly(A) RNA, from 
both broilers (101) and layers (71). The RNA was made from 
muscle from a single bird. 
Figure 4.7 shows the pattern found in 6 day post-hatch 
muscle. ODC13 hybridized to two bands in the broiler poly(A) 
track, and also, less strongly, to two bands in the layer poly(A) 
track. The amounts of ANA loaded in each track of the gel were 
not equal, therefore it is not possible to comment on the relative 
amounts of ODC mRNA present in broiler and layer muscle. It 
appears from the blot that there are two ODC transcripts of about 
1.7kb and 2.0kb in size in both broiler and layer. This is similar to 
the situation found in mouse and rat, but the transcripts appear 
to be smaller. However, it is emphasized that these sizes are only 
estimates. 
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FIGURE 4.7 NORTHERN BLOT OF CHICKEN RNA PROBED 
WITH ODC13 







Lanel: Total RNA from line 101. 
Lane2: Poly A - RNA from line 101. 
Lane3: Poly A RNA from line 101. 
Larie4: Total RNA from line 71. 
Lane5: Poly A- RNA from line 71. 
Lane6: Poly A RNA from line 71. 
Hybridization conditions: Hybridization was carried 
out in PIPES hybridization solution at 65°C for 16hrs. 
4.6 DISCUSSION 
After some initial difficulties encountered with the pOD54 
plasmid, interesting results were obtained from probing Southern 
blots of chicken genomic DNA. It was initially thought from 
results observed with the mouse cDNA probe pOD65 that there 
would prove to be multiple ODC pseudogenes in the chicken as had 
been found in mouse and rat. However, the pattern obtained using 
ODC13 (putative chicken ODC cDNA) as a probe make it likely that 
there is only one ODC gene in chicken. Two features in particular 
point to this; firstly the total size of the bands in a HindlIl digest 
of chicken DNA hybridising to ODC13 is around 7.5kb, which is 
similar in size to both the mouse and rat genes; secondly, 
different bands in the chicken genomic DNA hybridise to the 5' and 
3' ends of the cDNA, implying that they are fragments from 
different regions of the same gene. 
Another feature of the ODC gene shown by this study is the 
presence of a polymorphism at the 3' end of the gene. Judging 
from the intensity of the bands it was concluded that this was 
probably due to the presence of two different alleles in the 
broiler (101). It would be interesting to see if this polymorphism 
was present in other broiler strains. 
The results presented in Chapter 3 show that high levels of 
ODC activity occur in chick embryos at 4-5 days. From previous 
studies (Katz & Kahana, 1987; McConlogue et al, 1986) it was 
considered that this might well be due to increased mRNA levels, 
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so acDNA library made from this stage of embryo would be ideal 
to look for chicken ODC cDNA clones. 
From a 4 1/2 day chicken embryo library 14 positive clones 
were isolated using the mouse ODC cDNA. The longest was 1.7kb 
(ODC13) which although it was not quite full length, contained 
almost all of the coding region. The sequence analysis of this 
clone is presented in the following chapter. 
Northern blots of RNA from 6 day post-hatch muscle probed 
with ODC13 showed the presence of two transcripts of around 1.7 
and 2.0kb. This is consistent with the positions of the 
polyadenylation sites found in the cDNA (see Chapter 5), and the 
data presented for other species (Hickok et a!, 1986; Van Kranen 
et a!, 1987). In mouse it has been shown that the two ODC 
transcripts differ in size by about 400bp and that this is due to 
differences at the 3' end of the mRNA. 
Using the cloned chicken ODC cDNA it would now be possible 
to investigate further the organisation of the gene in chickens 
and to analyse the genomic clones already isolated. It would also 
be important to discover if there are two OUC transcripts in 
embryos, as found in muscle, and whether the levels of mRNA vary 
with the enzyme activity. 
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CHAPTER 5 




Ornithine decarboxylase cDNAs have been cloned and 
sequenced from several mammalian species as well as from yeast 
and trypanosomes. This has greatly facilitated studies of the 
control of expression of ODC as well as investigation of the 
organisation of the gene itself (Berger et a!, 1984; Kontula et a!, 
1984; Alhonen-Hongisto et a!, 1987; Wen et a!, 1989.) Mouse, rat, 
and human cDNA sequences have been published (Gupta & Coffino, 
1985; Kahana & Nathans, 1985; Hickok et a!, 1987; van Kranen et 
a!, 1987) and show considerable homology to each other and even 
between these and other published ODC sequences, e.g. 
trypanosome, there is considerable similarity. The homology is 
usually slightly higher at the amino acid level. Figure 5.1 shows 
percentage homologies for both DNA sequence and amino acid 
sequence between several species. 
Chapter 4 describes the isolation of cDNAs from a /2  day 
chicken embryo library with a mouse ODC cDNA probe. Altogether 
14 positive clones were isolated from the library. The most 
abundant of these was also the longest, being 1.7kb in size. This 
is similar in size to the human, mouse and rat ODC cDNAs in the 
Genbank database which are all around 1.9kb. It was decided to 
concentrate on sequencing one of these (ODC13) to try to 
establish that it did in fact code for ornithine decarboxylase. 
7.2. 
FIGURE 5.1 COMPARISON OF ODC SEQUENCES FROM DIFFERENT 
SPECIES (PERCENTAGE HOMOLOGY) 
MOUSE-RAT 94 % 99 % 




HUMAN-YEAST 58 % 62 % 
TRYPANOSOME- 
YEAST 56% 62% 
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5.2 SUBCLONING AND SEQUENCING OF ODC13 
ODC13 was first cloned as an intact fragment into 
M13mp18. This allowed the ends of the insert to be sequenced, 
showing significant homology to other published ODO DNA 
sequences therefore supporting the idea that this was a cDNA 
coding for chicken ornithine decarboxylase. 
The initial approach to sequencing the remainder of the 
fragment was to use a 'shotgun' cloning method (Sanger et a!, 
1980). The clone was cut with a number of restriction enzymes 
which have 4 base pair recognition sequences. This produces 
random fragments of about 250-350bp in size. These fragments 
were then cloned into M13 and sequenced. The relationship of the 
clones is not known beforehand, but determined after sequencing 
when the sequence generated in this way is searched for overlaps. 
When two sequences are found to overlap they can be joined to 
form a 'contig'. This process is continued until the sequence of 
the fragment is complete. 
In practice, about 0.9kb of the insert was sequenced using 
this 	strategy. However there seemed to be two regions totalling 
about 800bp which had very few restriction enzyme sites (see Fig 
5.2) 	and 	did not clone easily, 	so 	for 	these 	regions 	a different 
approach was used. 
The contigs 	which had 	been 	produced by 	the 	shotgun 
approach were lined up by comparison with the human sequence, 
so 	that it 	was 	possible to 	estimate 	where the 	gaps 	in 	the 
sequence were. Using the information gained in this way, a more 
7ct- 
FIGURE 5.2 PARTIAL RESTRICTION MAP OF ODC13. 
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HIIFe I i lHe 
0 	 500 	 1000 	 1500 
B=BamHI, I-Ie=HaeIlI, Hd=HindlII, P=PvuIl, S=Sau3AI. 
Enzymes which did not cut: BglII, Ecofli, Smal, SstI. 
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directed strategy was used to complete the sequencing of the 
clone. Specific restricition enzymes, known to cut close to the 
ends of the sequenced regions, were used. The fragments produced 
in this way were cloned into M13 and sequenced. This procedure 
was repeated until the sequence was complete (Fig 5.3). 
The complete sequence of clone ODC13 was 1688bp long. 
This was slightly shorter than the published mouse, human and 
rat cDNA sequences, but this was probably because the clone was 
not quite full length at the 5' end. By comparison with other ODC 
DNA sequences, it was estimated that ODC13 starts about 28bp 
after the initiation codon. The sequence of the clone and the 
projected amino acid sequence are shown in figure 5.4. 
The size of the ODC protein varies between species from 
445 to 466 amino acids (Fonzi & Sypherd, 1987; Kahana & 
Nathans, 1985; van Kranen et a!, 1987; Phillips et a!, 1987). It 
was calculated from comparison with these sequences that in 
chicken the full length peptide is probably made up of 460 amino 
acids, 450 of which are coded for by the sequence shown here. 
5.3 FEATURES OF THE ODC13 DNA SEQUENCE. 
Two potentially important features of the ODC13 sequence 
are highlighted in Figure 5.4. Although there was no poly (A) tail 
present in this clone, there are two possible polyadenylation 
signals. The first is immediately after the stop signal at position 
1258, the other is much nearer the 3' end of the clone, at position 
1679. This recognition sequence has been reported as normally 
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FIGURE 5.3 SEQUENCING STRATEGY FOR CLONE ODC13 
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FIGURE 5.4 DNA SEQUENCE OF ODC13 AND PREDICTED AMINO ACID 
SEQUENCE 
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181 GTAATGACAGTGAAGCTGTCGTGAAGACTCTTGCTGTTCTTGGTGCGGGATTTCATTGTG  
AsnAspSerGluA1aVa1Va1LysThrLeuA1ava1IeuG1yAIaG1yphegpj 
241 	 TGAGCGAATAATAT 
SerLysThrGluI leGinLeuValGinSerI leGluVaiProProGluArgIle I leTry 
301 	 CAAACATGCTGCTAACAGTGGTGTACGGA 
AlaAsnProCysLysGlnLeuSerGlnIleLysHisAlaAlaAsnSerGlyVaLArgPlet  
















901 	 TCAATTGCATCT 













TAA: STOP CODON 
POLYADENYLATION SIGNALS 
ATTTA: POSSIBLE RAPID DEGRADATION SIGNALS 
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lying about 20 nucleotides from the 3' end of most mRNAs 
(Proudfoot & Brownlee, 1976), so the second site is probably the 
active one for this particular clone. 
ODC gene expression has been shown to respond very rapidly 
to stimulii, such as IGF, growth hormone and testosterone. The 
rapid modulation of ODC levels and activity could be due, at least 
in part, to rapid turnover of the mRNA. It has been reported that 
mRNAs of transiently expressed genes often have a conserved AU 
rich region at the 3' untranslated end (Shaw & Kamen, 1986), and 
within this region a consensus sequence AUUUA is usually 
present. It has been proposed that this is a recognition signal for 
rapid degradation of the mRNA. This consensus sequence is 
present twice in the 3' untranslated region of 0DC13, and lies in a 
relatively AU rich region. 
The sequence of the clone ODC13 was compared to the ODO 
cDNA sequences in the Genbank database. Homology between this 
sequence and the mouse, rat and human sequences is fairly high, 
(about 78%). It also displays significant homology to the coding 
regions of S. cerevisiae and Ti. b. bwcei cDNAs (58% and 65% 
respectively). Dotplot comparisons between ODC13 and human 
cDNA (Fig 5.5) and ODC13 and Trypanosome cDNA (Fig 5.6) 
illustrate these similarities. In both cases the homology is 
highest in the coding region and less in the 3' untranslated 
terminal sequence. 
When ODC13 was used to search the Genbank database, the 
first 21 sequences with the greatest homology to this clone were 





FIGURE 5.5 DOTPLOT COMPARISON OF 00C13 AND HUMAN 
ODC cDNA 




FIGURE 5.6 DOTPLOT COMPARISON OF ODC13 AND 
TRYPANOSOME ODC cDNA 
CI3S.R,,, cM: XOS. 1 to L688  
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sequences were detected which showed significant homology to 
the ODC13 sequence. 
5.4 FEATURES OF PREDICTED CHICKEN ODC AMINO ACID 
SEQUENCE. 
The amino acid sequence deduced from the sequence of clone 
ODC13 is shown in Figure 5.4. Comparison with the ornithine 
decarboxylase peptide sequences of other species (also deduced 
from the published DNA sequences) show homology to be even 
higher than at the DNA level. This is demonstrated in Figure 5.7. 
Perfect matches and conservative substitutions across all the 
sequences are highlighted, but it can be seen that the matches 
between chicken, mouse, human and rat are very much more 
frequent. Homology between these sequences is 90-99%. Excluding 
the N teminal amino acids which are absent in the chicken 
sequence, there is only one gap in the alignment between these 
four sequences, at position 449, where there is one amino acid 
less in the chicken sequence. This is consistent with the 
differences between the other ODC amino acid sequences shown 
here, which differ mainly at the C terminus. 
It has been reported that proteins with particularly short 
half lives (less than 2 hours) often contain regions rich in proline 
(P), glutamic acid (F), serine (S), and threonine (T). These regions 
are characterised by clusters of positively charged amino acids 
and are known as PEST regions (Rogers et al, 1986). The presence 
of two PEST regions has already been demonstrated in the mouse 
Sc'- 
FIGURE 5.7 COMPARISON OF PREDICTED ODC AMINO ACID 
SEQUENCES. 
ODC13 	FT -------------------------------------- FL ------- DEGFTAXDILD 
HUMAN MNN ---------------------------- FGNEEFDCHFL ------- DEGFTAKDILD 
MOUSE 	MSS----------------------------FTKDEFDCHIL-------DEGFTAKDILD 
RAT MGS ---------------------------- FTKEEFDCHIL ------- DEGFTAKDILD 
TRY?. 	MTTKSTPSSLSVNC--LVAQTEK5M ---- DIVVIjDL5p --------EGFNTRDALC 
YEAST MSSTQVGNALSSSTTTLVDLSNSTVTQKKQYYKDGETLHNLLLELKNNQDLELLPHEQAH 
* 
ODd 3 	QRI ------------ NEVSSSDDKDAEYVADLGDIVXHmWHFMpRVTpFYAX7KdTJS 
HUMAN 01<1------------  NEVSSSDDKDAFYVADLGDILKKHLRWLKALPRVTPFYAVKCNDS 
MOUSE 	01<1------------  NEVSSSDDKDAFYVADLGDILKKHLRWLKALPRVTPFYAVKCNDS 
RAT 01<1 ------------ NEVSSSDDKDAFYVALGDV(HLRWLFPRV'PFYA\IKCS 
TRY?. 	1<1<1------------ 
YEAST PKIFQALKARIGRINNETCDPGEENSFF ICDLGEVKPLFNNWVKELPPIKPFYAVKCNPD 
ODd 3 	EAVVKTLAVLGAGFDCASKTEI0LVQSIGVPPEP1IY/PCKQLSQIYJJSGXITnRTF 
HUMAN KAIVKTLAATGTGFDCASKTEIQLVQSLGVPPEPJ IYAN?CKQVSQIKYAANNGVQITF 
MOUSE 	RAIVSTLAAIGTGFDCASKTEIQLVQGLGVPAERVIYANPCKQVSQIKYAASNGVQMMTF 
RAT RAIVSTLAAIGTGFDCASKTEIQLVQGLGVPPEPJ IYA?CKQV5QIKYSNQTF 
TRYP. 	WRVLGTLAALGTGFDCASNTEIQRVRGIGVPPEKIIYANPCKQISHIRYAPSJJMTF 
YEAST 
1. 	** *..*****..**. * ****** **..* ...* 	** 
ODd 3 	DSEVELMKIARPHPKAKLLLRITTDDSKAVCRLSVKFGATLKTSRLLLERAKELDLAIVG 
HUMAN DSEVELVAAHPKVLRIATDDSFAVCPWGATLRTSLLERALNIDWG 
MOUSE 	DSEIELMKVARAHPKAKLVLRIATDDSKAVCRLSVKFGATLKTSRLLLERAKELNIDVIG 








YEAST 	VSFHVGSGASDFTSLYKAVRDARTVFDKAANEYGLPPLKILDVGGGFQFES----- FKES 
ODC1 3 	TSVINPALDKYFPLDSEVTIIAEPGRYYVASAFTLAVNIIAKKIVSKEQTGSDDEDDVND 
HUMAN TGVINPALDKYFPSDSGVRI IAEL'GRYYVASMTLAVNI IAKKIVL}QTGSDDEDESSE 
MOUSE 	TSVINPALDKYFPSDSGVRI IAEPGRYYVASAITLAVNI IA1(TVWKEQPGSDDEDESNE 
RAT TSVINPALDKYFPSDSGVRIIAEPGRYYVASAFTLAVNIJAKKTVWKEQTGSDDEDESNE  
TRY?. 	AGVINNALEKHFPPDLKLTIVAEPGRYYVASAFTLAVNVIAKKVTPGVQTDVGAaAESNA 
YEAST TAVLRLALEEFFPVGCGVDI IAEPGRYFVATAFTLASHVIA1CPFJ JSENPJ __________ 
P1 
ODC13 
HUMAN 	QTFMYWNDGVYGSFNCILYDHpJjVfp ------------------- LLQKRPTCPDEKY-Y 
MOUSE QTFMYYVNDGVYGSFNCILYDHPJWK -------------------LLQKRPKPDEKY-y 
RAT 	QTLMYYVNDGVYGSFNCILYDHAJWKA ------------------- LLQKRPKPDEKY-Y 
TRYP. QSFMYYVNDGVYGSFNCILYDPAWPP ------------------- LPQREPIPNEa-y 
YEAST 	--- MIYTNDGVYGNMNCILFDHQEPHPRTLYHNLEFHYDDFESTTAVLDSINKTRSEYPY 











RAT SRSMWQIQIQSHGFPPEVEEQDVGTLPCAQESGMDPJ 4SCASAS 1W 
TRYP. 	SGLPDHVVRELKSQ------------------------------------ KS 
YEAST ----------------------------------nerT 
P2. 
• = Match across all sequences 
• Conservative substitutions 




6.1 WHY INVESTIGATE ODC ? 
To be able to control or manipulate growth, or factors 
involved in growth, in farm animals would obviously be of great 
commercial importance. Improvement of growth rate, weight-for-
age and muscle mass has been the aim of selection programmes 
for many years. It seems now that genetic manipulation 
techniques will be the most productive way to make significant 
improvements in these characteristics. 
This approach has already been used to dramatic effect in 
the introduction of the human growth hormone (GH) gene into 
mice, producing transgenic animals which are more than twice 
the size of their littermates (Palmiter et a!, 1983). To 
successfully apply this approach to manipulation of farm animals, 
however, it is necessary to know which gene products will 
produce the desired effects. Present knowledge in this area is 
limited; very little is known of which genes, or even how many, 
control commercially important traits such as growth rate. In 
other words, these so-called 'trait-genes' must be identified 
before we can even attempt manipulation of the traits they 
control. 
A number of factors have been shown to influence various 
aspects of growth, and in particular, muscle development, 
although the exact role of these factors and how they interact is 
not known. 
EEO 
As previously mentioned, growth hormone can have dramatic 
effects on growth in animals and has been demonstrated to 
increase growth rate and muscle growth in pigs. This occurs both 
in pigs treated with exogenous GH (Etherton, 1989) and in 
transgenic pigs with either human or bovine GH (Purse] et al, 
1989). It seems likely that GH exerts its effects on muscle 
growth via the insulin-like growth factors (IGFs) but the precise 
mechanism is unknown. 
lGFs are also known to have a positive regulatory effect on 
muscle growth. Both IGF-1 and IGF-11 stimulate muscle cell 
proliferation and the evidence suggests that both act via the type 
I IGF receptor (Goddard & Bulfield, 1990). As yet, the mechanism 
of IGF action on muscle cells is unknown, but it has been shown 
that IGF-1 induced elevation of polyamine content is essential to 
myoblast differentiation (Ewton et a!, 1984, Stoscheck et a!, 
1982). 
Fibroblast growth factor (FGF) and transforming growth 
factor-3 (TGF-) also play an important role in regulating muscle 
growth. Both of these factors stimulate proliferation and inhibit 
differentiation of myoblasts. TGF-0 controls differentiation of 
myoblasts by inhibiting accumulation of muscle specific gene 
products necessary for differentiation (Olson et a!, 1986). 
It is possible that these growth factors control the 
expression of genes such as Myd, MyoDi and myogenin which are 
thought to be part of some kind S  of cascade system committing 
muscle precursor cells to differentiation. It has been suggested 
that there is a simple regulatory pathway which mediates 
myogenic lineage determination and differentiation, which 
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involves these three genes (Pinney at a!, 1988). FGF and TGF-3 
have been demonstrated to inhibit differentiation by repressing 
MyoDl expression but there must be more than one mechanism 
involved as cells which constitutively express MyoDi can also be 
inhibited from differentiating (Vaidya at a!, 1989). 
Many of the postulated pathways and interactions involving 
these growth factors are, however, speculation, and obviously 
much more research in this area is needed before specific effects 
of a single gene product can be used to manipulate muscle growth. 
One of the approaches used to try to pinpoint specific 'trait 
genes' is to use animals divergently selected for the 
characteristics of interest and to assess physiological and 
biochemical differences between the strains. 
In chickens this involves using broilers, selected for muscle 
weight and growth rate, and layers, selected for egg production 
and effectively unselected for growth. The strains used in the 
work described here were also used in previous work on factors 
involved in growth. They differ up to 4-fold in body weight and up 
to 8-fold in muscle weight at 7 weeks of age (Bulfield at a!, 
1988). These strains have no differences in plasma IGF-1 levels 
despite their striking differences in growth rate, and GH levels 
were higher in the layers than in the broilers (Goddard at a!, 
1988). So it would seem that IGF-1 and OH are not responsible for 
these differences, but it is possible therefore that investigation 
of the role of the receptors for these substances may help to 
explain these observations. 
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Initial investigations of ornithine decarboxylase (ODC) 
activities in these strains have shown significantly elevated 
activity in the muscle of the broiler strain at 7 days post-hatch, 
which can be up to 20-fold higher than in layer muscle at this age 
(Bulfield et a!, 1988; see figure 6.1). This difference is not 
present in other tissues which implies a particular role for ODC 
in muscle growth. 
The work described in this thesis was based on the 
observations described above and is an attempt to investigated 
further the involvement of ODC in the differences in muscle 
growth in broilers and layers. The initial experiments repeated 
those carried out by Bulfield et a! (1988) in. investigating ODC 
activities in muscle of these strains. Again significant 
differences were found in muscle ODC activities, which were up 
to 6-fold at 6 days post hatch. This is immediately before a 
period of rapid growth and just at the point at which to post 
hatch differences in body and muscle weight between broiler and 
layer chicks start to appear. 
6.2 USE OF THE INHIBITOR DFMO 
The relationship between ODC and growth was further 
investigated by using DEMO to try to inhibit ODC activity in 
muscle (see Chapter 3). A similar experiment had previously 
shown that if DFMO was administered to chicks from hatch to five 
days, they did not grow at all and the muscle ODC levels at five 
days showed no increase over hatch levels. The criticism of this 
FIGURE 6.1 MUSCLE ODC ACTIVITY AND BODY WEIGHT IN 
SELECTED AND NON-SELECTED CHICKEN STRAINS. 
(From Buifield et a!, 1988.) 
Muscle ODC activity (a) and body weight (b) of chicken strains 
selected and non-selected for growth. Each point represents mean 
± s.e.m. of 8 measurements. 
Line L, a commercial layer line unselected for 
growth. 
Line S, a commercial broiler grandparent 'male 
parent' line. 
Line R, the same broiler line where selection has 
been relaxed. 
Qnttre Scaboxyiase activity (n ndes'nwg sn.scle) 










experiment was that DFMO was unpalatable and was putting the 
newly hatched chicks off their feed (G. Bulfield, pers. comm.).ln 
the experiment described in Chapter 3, I tried to overcome this by 
starting treatment later and monitoring food and water intake of 
the birds. Although the DEMO was given in the drinking water, the 
water intake for the experimental group was the same as for the 
control group. Food intake was slightly lower for the birds 
receiving DFMO but this was most likely because of their lower 
body weight, as smaller birds eat less. No significant difference 
was found in ODC activity between control and experimental 
groups until 49 days when the experimental group showed higher 
activity than the control birds. This was surprising, especially 
since the mean ODC activity of the experimental group was half 
that of the control group immediately after treatment, however 
this was not statistically significant because of the high 
variation in activity in the control group. When treatment was 
started at four days it was possible that the peak in ODC activity 
had already started and full inhibition was not achieved. This 
study therefore highlights the difficulty in treating very young 
animals with an inhibitor • which is known to suppress normal 
growth and development while trying to overcome the argument 
that it is generally toxic. 
The significant fact was, however, that after treatment the 
body weight of the treated birds was significantly lower than the 
control birds, and this difference was eliminated after treatment 
was stopped. 
When considered in conjunction with other reported effects 
of DFMO treatment (eg. on embryonic growth; Fozard et a!, 1980; 
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Lowkvist et a!, 1983; Lowkvist et a!, 1986; Mendez et a!, 1983) 
this provides further evidence that the effect of ODC on growth is 
a causal one. To prove this relationship convincingly by this type 
of experiment, however, seems to be virtually impossible as 
there will always be the argument that DFMO reduces food intake 
which in turn reduces the growth rate of the birds, rather than 
DFMO influencing the growth rate directly. 
DFMO may, however, prove useful in further work involving 
muscle cells in culture where this argument of unpalatiblity will 
not apply. 
6.3 ODC AND MUSCLE GROWTH 
Muscle formation begins in the embryo when myoblasts fuse 
to form myotubes. After birth, in mammals, or hatch, in birds, the 
myotubes elongate to form myofibres (Allen et a!, 1979). As the 
myofibres enlarge the muscle nuclei do not divide, but the nuclear 
to cell volume ratio remains more or less constant. This is 
achieved by the donation of nuclei to the myofibres by satellite 
cells associated with the fibres (Moss & Leblond, 1970; see 
Figure 6.2). The proliferative ability of the satellite cells seems 
to be the limiting factor in muscle growth. If this is the case 
then broiler muscle must differ from layer muscle in the number 
of satellite cells or their rate of proliferation. It is already 
known that ODC activity is necessary for both proliferation and 
differentiation of myoblasts (Erwin et a!, 1983) and that 
myoblasts and muscle satellite cells from selected and non-
selected chicken lines differ in rates of cell division (C. Goddard, 
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FIGURE 6.2 DIAGRAMMATIC REPRESENTATION OF MUSCLE 
DIFFERENTIATION 
Myoblasts line up 
in rows 
Fusion of myoblasts 
to form myotubes 
I Muscle fibre nuclei 
do not divide 
I 
Formation of muscle fibres 
and neuromuscular junction 
'Satellite cells 
capable of division 
and fusion with 
muscle fibre 
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unpub. obser.). Satellite cells and myoblasts in culture will 
therefore provide a means of further investigating the rote of ODC 
in muscle growth. 
6.4 ODC ACTIVITY IN EMBRYOS 
Muscle differentiation (myoblast fusion) begins in the 
embryo, so it was anticipated that the difference in muscle ODC 
activity between post-hatch broilers and layers might stem from 
embryonic differences in ODC activity, It seems, however, that 
although there is a peak in ODC activity at 4-5 days in the 
embryo, which is followed by a period of rapid growth, this is not 
related to the differences in muscle ODC activities post-hatch. 
Those strains which showed the highest embryonic ODC activity 
were not necessarily the fastest growing or heaviest strains 
post-hatch. It is true, however, that in every case the line which 
showed the higher peak activity was also the faster growing line 
at this stage. 
I have shown that ODC activity in 4-5 day embryos is 
highest in the head region in both broilers and layers and is 
probably associated with central nervous system development, 
which is in agreement with previous studies (Lowkvist et al, 
1985; 1987). At this stage of development there is rapid growth 
of brain and nervous tissue as well as muscle differentiation. 
There is also a peak in ODC activity later in embryonic 
development (10-11 days) and this might be involved in the 
differences in post-hatch muscle development. At this stage it 
might be possible to assay muscle alone for ODC activity to 
examine the possibility of differences between broiler and layer 
lines. 
The results I have obtained for ODC activities in chicken 
embryos correlate well with similar work done on mouse 
embryos. ODC activity has been measured in lines of mice 
selected for either high or low body weight over more than 
twenty generations. In these mice a peak in ODC activity was 
found in the 10-11 day embryos in all lines, which was 
consistently 2-3 fold higher in the 'high' lines ( A. Gray & A. Tait, 
pers. comm.). At 10 days the mouse embryo is at a similar stage 
of development to the chick embryo at 4-5 days, so it would seem 
that ODC plays a vital role at this particular point in embryonic 
development in both mammals and birds. 
6.5 THE CHICKEN ODC cDNA 
In order to examine the role that ODC plays in the 
differences in growth at a molecular level, I have cloned and 
sequenced a cDNA which almost certainly codes for chicken 
ornithine decarboxylase. The strongest evidence supporting this 
is the DNA sequence itself which is almost 80% homologous to 
published sequences for mammalian ODC cDNAs and the fact that 
it was identified by hybridization to a mouse ODC probe (Kahana & 
Nathans,1985). Further evidence is provided by the projected 
amino acid sequence of the clone which is also extremely 
homologous to mammalian ODC amino acid sequences. It shows 
almost 90% identity with the mouse and rat amino acid sequences 
predicted from the published DNA sequences (Gupta & Coffino, 
1985; Kahana & Nathans, 1985; Van Kranen eta!, 1987). 
This clone is not quite full length (it seems to start around 
28bp from the translation start site at the 5' end) but it will 
provide a useful tool for isolation of a complete cDNA and could 
be used in cloning of the chicken genomic ODC. It would be 
desirable to have a full length clone from which the entire amino 
acid sequence, of chicken ODC could be deduced and also for in 
vitro translation of the enzyme. 
The sequence of this cDNA provides a lot of important 
information about chicken ODC. As discussed in chapter 5 there 
are several potential regulatory features in both the DNA and 
predicted amino acid sequence. The presence of two transcripts in 
mice and rats has been extensively reported and this is due to the 
use of the two different polyadenylation sites. It therefore seems 
highly probable that the two transcripts that I have observed in 
chicken muscle are due to termination at the two potential 
polyadenylation sites in the sequence reported here. It would be 
interesting to establish if this is the case and if there is any 
tissue, strain or developmental specificity of the two mF1NAs. 
This has not so far proved to be the case in mouse, so what then 
is the reason for the two different size mRNAs? There are many 
reports of genes with two different sized transcripts arising 
from the use of two polyadenylation sites but no convincing 
reason for this has yet been forthcoming. 
The other potential regulatory feature of the cDNA is the 
ATITA motif, which is thought to be involved in rapid turnover of 
mRNA. This sequence has been reported in many transiently 
expressed mRNAs such as those for human c-myc and c-los, and 
mouse and human interleukin-2, a and f3 interferon, and 
granulocyte-monocyte colony stimulating factor (Shaw & Kamen, 
1986). The 3' untranslated region of the cDNA I have reported here 
is around 70% AT and contains two copies of the ATTTA 
consensus. It has been suggested that regulation of ODC could be 
at the mRNA level, so this might be one of the mechanisms 
involved. On the other hand, the examples used by Shaw and Kamen 
are much more AT rich in these regions and often contain more 
copies of the motif. It is also debatable how much effect the 
stability of the mRNA has on ODC regulation since several recent 
publications point to mainly translational and/or post-
translational regulation (Dircks et al, 1986; Van Daalen Wetters 
et a!, 1989). 
The amino acid sequence predicted from the sequence of the 
cDNA contains two probable 'PEST' regions, a feature consistent 
with post-translational regulation of the enzyme. The presence of 
'PEST' regions has been observed in other proteins with rapid 
turnover such as c-los and c-myc, as well as in ODC amino acid 
sequences from other species (Rogers et a!, 1986). The evidence 
for post-translational regulation of ODC is very strong (Dircks et 
a!, 1986; Glass & Gerner, 1987; Russell, 1981; Seely eta!, 1982a; 
Van Daalen Wetters et a!, 198 9) It has recently been shown that a 
carboxyl-terminal truncated mouse ODC protein with only the 
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first 424 of 461 amino acids, is expressed in CHO cells but has a 
half-life of about four times that of the native enzyme (Ghoda et 
al, 1989). Amino acids 425-461 contain the second of the two 
PEST regions in mouse ODC. This is the region which is not 
present in yeast and trypanasome ODCs which are known to have 
longer half lives than the mammalian proteins. 
6.6 THE ORGANISATION OF THE ODC GENE 
A feature of the ODC gene in rodents is that it appears to 
belong to a family of multiple pseudogenes, of which probably 
only one is a functional transcribed gene. In humans there have 
been only two genes identified, one of which is a functional gene. 
I have shown that in chickens there appears to be only one 
gene which hybridizes to the chicken cDNA, but there are many 
which hybridize to the mouse cDNA. This implies that there is 
only one functional gene in chickens and if there are pseudogenes, 
as found in other species, they are probably divergent as they can 
only be detected by Southern blotting under conditions of low 
stringency. 
When Southern blots of broiler and layer DNA digested with 
the enzyme Haelll are probed with the chicken ODC cDNA, a 
polymorphism is detected in the form of an extra band in the 
broiler DNA. This is probably an allelic difference in the broiler 
strain used and I have shown that it occurs at the 3' end of the 
gene. It is possible that this is a marker for a haplotype involved 
in differences in growth, and therefore it would be interesting to 
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examine DNA from other broiler strains to see if this difference 
is present. It would also be very useful to discover the nature of 
this polymorphism. Is it in the coding region of the gene, and if 
so, is it a single base change in the sequence and what effect, if 
any, does it have on the peptide sequence? 
This polymorphism is also very interesting in the light of 
the results obtained with the strains of mice selected for high 
and low body weight mentioned earlier. In these mice a 
polymorphism was also found in the ODC gene. Again the 
difference is found when the DNA is cut with HaellI, and takes the 
form of an extra band which hybridizes to the ODC cDNA, but it is 
at the 5' end of the gene (A. Gray & A. Tait, pers. comm.). This 
extra band is fixed in all three lines selected for high body 
weight and is not present in any of the low body weight lines. 
Again this is evidence for a haplotype associated with the 
differences in growth rate between the lines. 
6.7 EXPRESSION OF ODC 
I have shown that both broiler and layer strains express two 
species of ODC mRNA in muscle. I have estimated these to be 
around 1 .7kb and 2.0kb, which is what would be predicted from 
the sequence of the cDNA reported here, if the two transcripts 
are due to the use of the two polyadenylation sites. 
Using the ODC cDNA as a probe it will be possible to 
discover if embryos also express two ODC mRNAs, and if there is 
any relative difference in expression of the two transcripts in 
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either broiler or layer, or in embryos as compared to muscle. So 
far the indications from patterns of expression in other species 
are that there is little if any difference in relative levels of 
expression of the two transcripts (Hickok et al, 1986; Van Kranen 
et a!, 1987). 
If the only difference in the two transcripts is a difference 
in size in the 3' untranslated region then it seems likely that the 
two transcripts might differ in stability due to differences in 
mRNA secondary structure. It is possible, if this is the case, that 
the less stable transcript is expressed when levels of ODC 
activity are low, and that an increase in expression of the other, 
more stable transcript, causes a rise in ODC activity, possibly 
under conditions of rapid growth as found in the 4-5 day embryos. 
Having found differences in ODC activity between muscle 
and embryos of broiler and layer strains, the use of this cDNA 
will allow examination of the mechanisms involved. In the mouse 
lines mentioned earlier, selected for high and low body weight, 
the differences in embryonic ODC activity were found to be due to 
differences in expression (A. Gray & A. Tait, pers. comm.). It 
would now be possible to discover if this is also the case in 
chicken embryos and muscle. 
6.8 FURTHER INVESTIGATION 
There are many pathways opened up by the experiments 
described here which are worthy of future investigation. 
The use of cell culture will be important in examining the 
role of ODC in muscle growth in particular, as myoblasts and 
satellite cells are already available in culture and will be quicker 
and more convenient than the use of experimental animals for 
initial experiments on the regulation of ODC. In particular this 
system could be used to investigate the effects of growth factors 
and mitogens such as IGF-1, growth hormone, and TGF-13, on both 
ODC activity and expression in muscle. Conversely the effect of 
inhibiting ODC with DFMO could also be examined in this system 
without the argument of unpalatability which is brought up 
against treating whole animals with this inhibitor. 
The cDNA described in Chapters 4 and 5 will allow access to 
a new area of investigation in chickens. The most obvious next 
step would be to examine the nature of the differences in ODC 
activity found between broiler and layer lines both in post-hatch 
muscle and in embryos. Is this due to differences in expression as 
was found in the mouse lines selected for high and low body 
weight ? 
Further examination of the organisation of the gene and the 
polymorphism found here will also be possible. Using the chicken 
ODC cDNA, and the genomic clones already isolated, it should be 
relatively simple to clone the whole gene from both broiler and 
layer as it is now known to be around 7-8kb in length. 
Now that the sequence for chicken ODC is known, and once 
the gene itself has been cloned, several other approaches should 
also be possible. Gene targeting could be used to 'knock out' the 
ODC gene in satellite cells and myoblasts, or in fibroblasts to 
examine the effect on replication and differentiation. This may, 
however prove to be extremely difficult to achieve, since there 
are many technical difficulties involved. Also, knocking out the 
ODC gene may prove to be lethal to the cells. 
The use of transgenics would also enable investigation of 
the effect of extra copies of the ODC gene in whole animals. The 
chicken gene seems to be highly enough conserved to allow 
expression in transgenic mice, but it is also likely that the 
production of transgenic chickens is not too far away. 
6.9 SUMMARY AND CONCLUSIONS 
The work described in chapter 3 emphasises some of the 
difficulties in establishing a causal relationship between any 
substance and its apparent effect in vivo. It is, however, evident 
that there is a close relationship between ornithine 
decarboxylase activity and increased muscle growth in chickens 
selected for rapid growth and muscle weight. I believe I have 
overcome some of the arguments of general toxicity of DFMO in 
these experiments, and the use of this inhibitor is an important 
system for establishing the relationship between ODC and growth, 
although probably not in its use in experimental animals. 
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I have shown that the connection between faster growth and 
higher ODC activity is also present in embryos, the difference 
being that in embryos at the stage examined here it does not 
appear to be related to post-hatch muscle development. 
I have also cloned and sequenced a cDNA for chicken ODC. 
This opens up a different approach to examining the function of 
ornithine decarboxylase in muscle growth. It provides a valuable 
tool for investigation of the control of expression of the gene, the 
possible differences between broiler and layer genes and study of 
the molecular genetics of ODC in cultured satellite and myoblast 
cells. 
The presence of a polymorphism in the ODC gene in broilers, 
the significantly higher ODC activity in broiler muscle and the 
peak found in ODC activity immediately before a period of very 
rapid growth both in embryos and in post-hatch birds, all imply a 
major role for ODC in the regulation of growth. 
It is still difficult to speculate on an exact function for 
ODC in the regulation of growth. Several possibilities present 
themselves from the evidence of previous experimental results, 
much of which has been reviewed in chapter 1, and those 
presented here. What is certain is that ODC is vital for 
biosynthesis of polyamines and that polyamines influence many 
aspects of cell growth. In particular, RNA and DNA synthesis, 
which are vital for cell division, are stimulated by increased 
polyamine concentrations and inhibited by lack of polyamines. It 
is also well established that many mitogens and growth factors 
increase ODC activity and therefore polyamine levels in the cell. 
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From this it can then be postulated that ODC acts in a similar way 
to 'second messenger' or signal transduction system between 
growth factors and their effects on DNA, RNA and cell division. 
It is possible, however, that ODC has other functions as 
well as its involvement in polyamine biosynthesis which could 
point to a more direct role in cell growth and division. There is 
evidence that ODC itself has an affinity for RNA polymerase 1 and 
is therefore involved in stimulation of transcription (Manen & 
Russell, 1977; Russell, 1983). It has also been suggested that ODC 
is involved in the inositolphosphate/diacylglycerol signal 
transduction system (Mustelin et a!, 1987). 
So the argument remains as to whether ODC is a 'trait gene' 
which is directly involved in faster growth in selected animals, 
or it is some other gene or genes which are selected for and the 
effect on ODC is a secondary one. It seems that the only way to 
decide this is to directly manipulate the ODC gene in cells and 
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